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Abstract
Spermatogenesis is a complex process of male germ cell proliferation and maturation from diploid
spermatogonia to haploid spermatozoa that can fertilize the female germ cell and transfer genetic
information to the offspring. During spermatogenesis, programmed cell death, i.e. apoptosis,
plays an important role in limiting the germ cell population and eliminating germ cells that are
defective or that carry DNA mutations. Dysregulation of this physiological germ cell apoptosis
can cause male infertility. Inappropriate germ cell apoptosis may also result from external
disturbances such as alterations in hormonal support, or exposure to toxic chemicals or radiation.
In this respect, exposure to environmental toxicants and hormone-like compounds has been
suggested to cause declining sperm counts and male fertility problems. Moreover, survival of
cancer patients treated with radiation and chemotherapeutic drugs has increased but the treatments
may cause germ cell loss and infertility. Thus, there is a growing need to understand the mechanisms
of germ cell death and to find ways to prevent its inappropriate occurrence. Present knowledge of
male germ cell apoptosis is based largely on studies conducted in experimental animals, which, in
view of potential species specificity of cellular responses to death-inducing stimuli, are not
appropriate models for humans.
The present series of studies aimed at characterizing the regulation of the initiating events in
human male germ cell apoptosis, using culture of human seminiferous tubules as a model of the
physiological stress situation. In this model, exposure of the seminiferous tubules to serum-free
culture conditions induced massive germ cell apoptosis within a few hours. The studies specifically
addressed i) the role of the testicular steroid hormones 17β-estradiol and dihydrotestosterone
(DHT) in the regulation of male germ cell death, ii) the involvement of the signaling pathways
initiated by the cellular death-inducing receptors Fas and the tumor necrosis factor α receptor 1
(TNFR1) in human male germ cell apoptosis, and iii) the possibility of preventing stress-induced
apoptotic death of male germ cells by pharmacological modulation of the apoptotic pathways
characterized in the present studies. The experiments revealed that 17β-estradiol is a survival
factor for male germ cells, being an even more potent inhibitor of germ cell death than the androgen
DHT. Regulation of germ cell apoptosis was found to involve signaling pathways triggered by the
ligands of Fas and TNFR1, i.e. Fas ligand (FasL) and tumor necrosis factor α (TNFα), respectively.
While the Fas system appeared to mediate germ cell death, the TNFα-induced signaling was
associated with down-regulation of the Fas system and inhibition of germ cell apoptosis. The
transcription factor nuclear factor κB (NF-κB), which is often considered to be a mediator of TNFα-
induced survival signals, appeared not to mediate the anti-apoptotic effect of TNFα, but rather to
be involved in testicular pro-apoptotic pathways that function in parallel with or downstream of
that triggered by Fas. Finally, germ cell apoptosis could be prevented by pharmacological modulation
of the pathways described in the present studies. Many of the effective compounds are commonly
used anti-inflammatory drugs.
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In conclusion, the present studies revealed that i) physiological estrogens can be considered to
be survival factors of male germ cells, which should be taken into account when evaluating the
effects on male fertility of compounds able to modulate hormonal signaling, ii) the cytokines FasL
and TNFα regulate male germ cell death, most likely through activation of their receptors Fas and
TNFR1, respectively; FasL mediates germ cell apoptosis and TNFα decreases the level of FasL
and inhibits apoptosis, and iii) in vitro-induced male germ cell apoptosis can be prevented by
anti-inflammatory drugs, which raises the possibility of pharmacological suppression of germ cell
apoptosis during cancer therapies and other transient stress situations involving excessive germ
cell death.
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Introduction
Spermatogenesis is a complex process of male germ cell proliferation and maturation from
spermatogonia to spermatozoa. During this process, the number of germ cells has to match the
nursing capacity of the somatic Sertoli cells, which provide the structural and functional support
for germ cell development. In this regard, apoptotic cell death plays an important role in limiting
the testicular germ cell population during male development. In the adult testis, also, physiological
apoptosis occurs at various phases of spermatogenesis. Dysregulation of germ cell apoptosis, in
turn, may cause male infertility. Testicular stress caused by external disturbances, such as alterations
in hormonal support or exposure to toxic chemicals or radiation, can cause increased apoptosis
leading to pathological germ cell loss. Indeed, exposure to environmental toxicants or chemicals
able to modulate hormonal signaling has been suggested to be one reason for declining sperm
counts observed in young men. Furthermore, treatment of cancer with radiation or with
chemotherapeutic drugs induces germ cell death and may lead to infertility. Accordingly, there is
a growing need to study the mechanisms of apoptosis in the testis and to find ways to promote
male germ cell survival.
The sensitivity of the seminiferous epithelium to external disturbances such as exposure to
radiation, to certain chemotherapeutic compounds, or to in vitro culture conditions varies between
species. Therefore, results obtained with animal models cannot always be extrapolated to the
process of human germ cell death. In the present study, culture of human seminiferous tubules
was used as a model for the study of germ cell apoptosis. The culture of seminiferous tubules
models the situation in which human testicular homeostasis is threatened and demonstrates how
different types of cells in the seminiferous epithelium may act during stress. The present study
aimed at characterizing the effects of two testicular steroid hormones, 17β-estradiol and
dihydrotestosterone (DHT), on male germ cell death, and the roles of two important induction
pathways of apoptosis, the Fas ligand (FasL)- and TNFα-induced pathways, in germ cell apoptosis.
Moreover, the present study attempted to find out whether pharmacological modulation of these
apoptotic pathways could be used to prevent excessive male germ cell apoptosis.
11
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Spermatogenesis
Spermatogenesis is a complex process of male
germ cell proliferation and maturation from
diploid spermatogonia through meiosis to
mature haploid spermatozoa (1). It takes place
in the seminiferous tubules of the testis, which
consist of (i) the seminiferous epithelium,
composed of germ cells and supportive somatic
Sertoli cells, (ii) the basement membrane, and
(iii) the surrounding peritubular myoid cells
(Figure 1A). The interstitial tissue between the
seminiferous tubules contains androgen-
producing Leydig cells and interstitial
macrophages.
Development of the testis
Spermatogonia arise from the primordial germ
cells, which migrate into the genital ridge during
fetal life (2-4). Under the influence of the Y-
chromosome-bearing stromal cells of the
developing gonad, they differentiate into
gonocytes, the male germ cell precursors, and
undergo mitotic arrest (4). After birth, they are
reactivated and differentiate into spermatogonia
(3,5). In the human testis, the transformation of
gonocytes into spermatogonia occurs during
the first six months of postnatal life,
simultaneously with a transient increase in the
serum concentrations of follicle stimulating
hormone (FSH), luteinizing hormone (LH), and
testosterone (6). Small numbers of
spermatogonia may occasionally differentiate
into meiotic primary spermatocytes in the
immature human testis, but the vast majority of
the germ cells do not undergo meiosis until
several years later at puberty (6,7).
Adult spermatogenesis
At puberty, remarkable anatomical, cytological,
and functional changes occur in the testis.
Sertoli cells cease mitotic divisions, Leydig cells
differentiate and produce testosterone in
response to LH, and germ cells proliferate
intensively and initiate meiosis (7,8). With the
initiation of spermatogenesis, groups of germ
cells enter the spermatogenic process at regular
intervals (5,9). Therefore, germ cells differing in
the degree of maturation are not randomly
distributed in the seminiferous epithelium, but
are arranged in defined associations called
stages of the seminiferous epithelial cycle (10).
The cycle of the seminiferous epithelium is the
time interval between the appearance of the
same stage at a certain point of the tubule. The
number of stages is constant for a given
species. In the human, 6 stages have been
defined (Figure 1B) (10). In most species, a
particular stage occupies a relatively long
segment of a seminiferous tubule, resulting in
the appearance of only one stage in a cross-
section of a tubule (11). In the human testis, in
contrast, the stages are spirally oriented, leading
to the typical finding of several irregular cell
associations in a given cross-section (12). The
duration of the maturation of a spermatogonium
to spermatozoa is also species-specific being
approximately 70 days in the human testis (12).
Spermatogenesis involves (i) spermatogonial
proliferation, (ii) meiosis, and (iii)
spermiogenesis (1). Spermatogonia proliferate
by mitotic divisions. The germline stem cells
known as A
single (As) spermatogonia, which
constitute a minority of the basal germ cells in
12
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Fig. 1. Human seminiferous epithelium. A. Schematic illustration of the structure of human seminiferous
epithelium. Germ cells at different phases of differentiation (light gray) are in close contact with the
supportive somatic Sertoli cells (SC; dark gray), which form junctional complexes (JC) between each other
to produce two compartments of the seminiferous epithelium. The basal compartment below JC contains
spermatogonia and early spermatocytes and the adluminal compartment above JC contains later
spermatocytes and spermatids. The junctional complexes between Sertoli cells form a barrier that prevents
penetration of blood-derived substances into the adluminal compartment where meiosis takes place. The
cells of the seminiferous epithelium are separated from the interstitial tissue by the basal lamina (BL) and
peritubular myoid cells (MC).
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contact with the basement membrane, are single
cells that can divide into two new stem cells or
into germ cells destinated to differentiate (5,13).
From then on, the germ cells consist of
interconnected cells of increasing size, because
the dividing cells remain connected by
cytoplasmic bridges. As germ cell maturation
proceeds, these cell syncytia leave the
basement membrane and move in a highly
ordered manner toward the lumen of the
seminiferous tubule. In the human testis, two
types of spermatogonia, A spermatogonia and
B spermatogonia, are present (12,14,15). Type
Adark spermatogonia are thought to be reserve
stem cells, with a low division rate (12,14). Type
Apale spermatogonia renew more frequently and
differentiate into type B spermatogonia, which
enter the last mitosis of spermatogenesis and
give rise to preleptotene primary spermatocytes
(12). This is followed by the long prophase of
the first meiotic division, during which
homologous chromosomes pair and the primary
spermatocytes increase in size and demonstrate
distinct nuclear morphology as they pass
through the steps of leptotene, zygotene,
pachytene, and diplotene (10,12). The first
meiotic division is completed after a rapid
metaphase, anaphase, and telophase, giving rise
to secondary spermatocytes, which undergo the
short second meiotic division to form haploid
spermatids (12). Finally, during spermiogenesis,
a series of transformations of haploid spermatids
ultimately leads to the formation of spermatozoa
(1,12).
B. Cycle of the human seminiferous epithelium. Germ cells at different phases of differentiation are arranged
in six defined cell associations, i.e. stages, of the cycle of the seminiferous epithelium (roman numerals).
In humans, the stages are oriented spirally, leading to the occurrence of irregular areas from several
different stages in a cross section of the seminiferous tubule. The direction of germ cell maturation from
spermatogonia to spermatozoa is indicated by arrows. The excess cytoplasm which is partitioned off from
the spermatid in its final phase of maturation is called the residual body (Rb). Thereafter, the germ cell is
released from the seminiferous epithelium as a spermatozoon (Sz). The illustrations are based on those of
Y. Clermont (10).
The production of a normal number of
spermatozoa depends on the highly specific
regulation of gene expression in the germ cells,
the paracrine and hormonal control of germ cell
proliferation, differentiation, and survival, and
the structural and functional support of the germ
cells provided by the Sertoli cells (1,9,16-18).
Importantly, it is becoming increasingly clear
that the specialized functions required for proper
proliferation and differentiation of the
spermatogonial stem cells are mainly provided
by the neighboring differentiated Sertoli cells.
The Sertoli cells, possibly together with the
adjacent basement membrane, create a particular
microenvironment, termed ‘niche’, which
controls the renewal and differentiation of the
stem cells (13). Moreover, the cells of the
seminiferous epithelium form Sertoli-Sertoli cell
and Sertoli-germ cell junctions that mediate
adhesive contacts and transmit signals between
contiguous cells and that are known to
contribute in a crucial way to germ cell
maturation (19-22). In the basal region of the
seminiferous epithelium neighboring Sertoli
cells form specialized junctional complexes,
which are composed of i) tight junctions, ii)
unique actin-related dynamic junctions termed
ectoplasmic specializations, and iii) adhesive
intermediate filament-based desmosome-like
junctions. These junctional complexes divide
the seminiferous epithelium into two distinct
microenvironments, a basal compartment that
contains spermatogonia and preleptotene
14
Review of the Literature
spermatocytes and an adluminal compartment
that contains later spermatocytes and
spermatids. They form a barrier which prevents
penetration of many hazardous, blood-derived
substances into the adluminal compartment
where meiosis takes place. Desmosome-like
junctions are also present between the Sertoli
cells and the round spermatids. As the
spermatids mature, the desmosome-like
junctions are replaced by ectoplasmic
specializations, which persist until spermiation,
when the final junctions between Sertoli cells
and germ cells called tubulobulbar complexes
form. The turnover of the ectoplasmic
specializations enables spermatocytes to move
from the basal to the adluminal compartment
and the release of sperm. Finally, gap junctions,
i.e. intercellular membrane channels that allow
cells to communicate directly with one another,
are present between the Sertoli cells, between
the Sertoli cells and the spermatogonia/
spermatocytes, between the cells of the
peritubular layer, and between the Leydig cells.
Gap junctions provide a means for the efficient
transport of nutrients to cells located far from
the blood supply and a conduit for the sharing
of small metabolites and second messengers (22-
25). Thus, the fine architecture of the
seminiferous epithelium and the interactions
between different types of seminiferous
epithelial cells are crucial for spermatogenesis.
Apoptotic cell death in the
testis
Apoptosis
Apoptosis, also known as programmed cell
death, is a form of cell death in which the cells
activate an intracellular death program and kill
themselves in a controlled way, i.e. commit
suicide (26). During development, structures
that are no longer needed are removed by
apoptosis. Throughout life, apoptosis eliminates
cells that are useless or potentially dangerous
to the host such as aged, infected, injured, or
mutated cells, or cells that are produced in
excessive amounts, such as germ cells in the
testis. During apoptosis, the cells shrink and
exhibit several typical features, including cell
membrane disruption, cytoskeletal
rearrangement, nuclear condensation, and
internucleosomal DNA fragmentation (27). The
degradation of DNA into fragments
approximately 185 bp and its multiples in size is
one of the best characterized biochemical
features of apoptotic cell death and is used as
the basis for the commonly used labeling
techniques for detecting apoptotic cells (28).
Apoptotic cells are usually rapidly taken up and
degraded by neighboring cells before their
intracellular contents leak into the extracellular
space. In contrast, acute accidental injury may
lead to an uncontrolled form of cell death, called
necrosis, which is characterized by swelling and
bursting of the dying cells, with an
accompanying inflammatory response (26).
Caspase activation
Most of the morphological changes in apoptotic
cells are caused by specific proteases,
caspases, that share the ability to cleave their
substrates on the carboxyl side of aspartate
residues (27,29). Today, 14 mammalian caspases
have been identified of which caspases-2, -3, -
6, -7, -8, -9, and -10 have been implicated in
apoptosis. The caspases are synthesized as
enzymatically inactive zymogens, which in most
cases are cleaved proteolytically to produce the
active enzyme (30). Caspase activation may
result from various intra- and extracellular death-
inducing signals and, depending on the cell
15
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type, is mediated via mitochondria-independent
or -dependent pathways (Figure 2) (27,31).
In the death receptor pathway, cell-surface death
receptors, such as Fas or tumor necrosis factor-
α receptor 1 (TNFR1), are activated by ligand
binding and recruit several cytoplasmic adapter
proteins through homotypic interactions
between special interaction domains (27). The
resultant membrane-bound signaling complex
then recruits several molecules of procaspase-
8, which is considered to be the key initiator
caspase in the death-receptor pathway (32).
Under these conditions, the procaspase-8
molecules are believed to cleave and activate
each other (30,32). From this point, the apoptotic
signal is mediated via a mitochondria-
independent or dependent pathway, depending
on the cell type (27,32). In type I cells (e.g.
various lymphoid cells), active caspase-8
cleaves large amounts of downstream effector
caspases, such as caspase-3, -6, and –7,
resulting in effective commitment to apoptosis
independently of mitochondrial events. In type
II cells (numerous other cells), only small
amounts of active caspase-8 are formed and the
signal is amplified through activation of the
mitochondrial pathway.
The mitochondrial pathway of caspase
activation involves mitochondrial events such
as membrane permeability transition (PT), with
resultant release of mitochondrial proteins such
as cytochrome c into the cytoplasm (27,33).
When released into the cytoplasm, cytochrome
c binds to Apaf-1 (apoptotic protease-
activating factor-1), resulting in the assembly
of a high molecular-mass complex called the
apoptosome, which contains cytochrome c,
Apaf-1, and procaspase-9 (27,34). The
interaction between Apaf-1 and procaspase-9
leads to the formation of an active caspase-9
which, in turn, proteolytically activates caspase-
3. In the death receptor-initiated pathway of the
type II cells, the release of cytochrome c from
the mitochondria results from caspase-8-
mediated cleavage of a cytoplasmic Bcl-2 family
member Bid. Bid can also be activated
proteolytically by the cytotoxic lymphocyte
protease granzyme B and by certain lysosomal
cathepsins (27). Importantly, various stimuli can
induce PT and thus the release of cytochrome c
independently of any caspase-8 activation (33).
In both the mitochondria-independent and -
dependent pathways, the proteolytic activity
of the effector caspases eventually results in
the destruction of vital proteins and the death
of the cell. In most cases, caspase-mediated
cleavage causes inactivation of the substrate
proteins, such as polyADP-ribose polymerase,
or destruction of macromolecular structures
such as the lamin network (30). In addition,
caspases activate other proteins that are needed
for the achievement of apoptosis by cleavage
of regulatory domains. One of these proteins is
caspase-activated DNase (CAD), which is
responsible for apoptotic DNA fragmentation
(28).
Intracellular regulators of apoptosis
Apoptotic pathways are regulated by numerous
intracellular factors. The Bcl-2 family of proteins
is a major class of intracellular apoptosis
regulators (27,35). The Bcl-2 family can be
divided into anti-apoptotic members, such as
Bcl-2, Bcl-xL, and Bcl-w, and pro-apoptotic
members, such as Bax, Bak, Bid, and Bad.
However, recent evidence indicates that
caspase-mediated cleavage of the anti-
apoptotic Bcl-2 family proteins may convert
them into pro-apoptotic mediators (36). It is
16
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Fig. 2. Multiple pathways of apoptosis. Apoptotic pathways can be initiated by the binding of death-
inducing cytokines, such as the Fas ligand (FasL) or the tumor necrosis factor α (TNFα), to their cell
membrane receptors, by various other extracellular stress stimuli, or by intracellular stimuli such as DNA
damage. Activation of the death receptors is followed by recruitment of several adapter proteins and
consequent activation of procaspase-8. A number of intracellular factors, such as transcription factors
nuclear factor-κB (NF-κB) and activating protein-1 (AP-1), may be simultaneously induced in response to
death-inducing stimuli to regulate the apoptotic pathways. In the mitochondria-independent pathway, activation
of caspase-8 leads to direct activation of effector caspases such as caspase-3. In the mitochondria-
dependent pathway, caspase-8 cleaves the pro-apoptotic Bcl-2 family member Bid, yielding a fragment
(tBid) that translocates into mitochondria, where it takes part in mitochondrial events such as membrane
permeability transition (PT) and release of cytochrome c (cyt c) into the cytoplasm. Various caspase-
independent extracellular and intracellular stimuli can also induce these mitochondrial events. Pro-apoptotic
Bcl-2 family members, such as Bax, facilitate the release of cyt c, whereas anti-apoptotic Bcl-2-like
proteins function to prevent their action. The tumor suppressor protein p53 mediates apoptosis by inducing
transcription of genes encoding pro-apoptotic proteins, such as Bax and Fas, and possibly also by
transcriptionally independent activities, such as relocalization of death receptors from Golgi to the cell
surface and direct signaling at the mitochondria. Reactive oxygen species (ROS) formed in the mitochondria
during apoptosis can regulate the apoptotic cascade at various levels. Once in the cytoplasm, cyt c
promotes assembly of procaspase-9 and Apaf-1 into a macromolecular complex called the apoptosome.
The anti-apoptotic heat shock proteins (HSPs) may prevent the formation of the apoptosome. Assembly of
the apoptosome results in the formation of the active caspase-9 which, in turn, proteolytically activates
caspase-3. Thus, the mitochondria-independent and –dependent apoptotic pathways converge at the level
17
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generally believed that the ratio of pro-
apoptotic to anti-apoptotic Bcl-2 family
members is critical in determining whether the
cell will undergo apoptosis. A major function of
the Bcl-2 family members appears to be the
regulation of mitochondrial events, such as
release of pro-apoptotic factors (27,33,35).
Various transcription factors appear to regulate
cell death. The tumor suppressor p53 regulates
both cell proliferation and apoptosis (37). In
response to various stress signals, it can
promote apoptosis by enhancing transcription
of the genes involved in apoptotic pathways
(38,39). However, p53 may also contribute to
the regulation of apoptosis by transcriptionally
independent activities, such as relocalization of
death receptors from Golgi to the cell surface
and direct signaling at the mitochondria (38,39).
Two other transcription factors, nuclear factor-
κB (NF-κB) and activating protein-1 (AP-1), are
also known to play roles in both cell proliferation
and apoptosis (40-43). Both may be activated in
response to various stimuli, such as TNFR1
activation (44,45), and both appear to either
promote or inhibit apoptosis, depending on the
cell type and the experimental model used (40-
42).
In addition, several other intracellular molecules
have been shown to regulate apoptosis. Heat
shock proteins (HSPs), which accumulate in cells
in response to stressful stimuli, can regulate
apoptosis by acting as molecular chaperones
that influence the assembly of protein
complexes, such as the apoptosome, or by
protein-protein interactions that are not related
to their chaperone function (46,47). In general,
HSP27, HSP70, and predominantly also HSP90
are anti-apoptotic, while HSP60 and HSP10 are
pro-apoptotic. Furthermore, enzymatic
hydrolysis of cell membrane lipids produces
bioactive molecules such as the sphingolipids
ceramide and sphingosine-1-phosphate (S1P)
(48). Several stress agents cause intracellular
accumulation of ceramide, which is usually
found to be associated with the induction of
apoptosis (48,49). S1P has been suggested as
an antiapoptotic factor and the balance between
the cellular concentrations of ceramide and S1P
has been suggested to determine whether the
cell will undergo apoptosis or survive (50).
Finally, numerous additional intracellular
molecules may contribute to the regulation of
apoptosis. Among these are cellular caspase
inhibitors, such as IAPs (inhibitors of apoptosis
proteins) and FLIPs (FLICE, i.e. caspase-8,
inhibitory proteins), and polypeptides released
from the mitochondria, such as AIF (apoptosis-
inducing factor), endonuclease G, and SMAC
(second mitochondrial activator of caspases,
also called Diablo) (27,32).
Caspase-independent apoptosis
Apoptosis can be induced by overexpression
of Bax even when the activity of caspases is
blocked, suggesting that caspase activity is not
essential in all types of apoptosis (51).
Moreover, apoptosis-like chromatin
condensation has been reported in some cell
types dying in the presence of caspase
inhibitors (52). As Bax is known to induce PT,
the energy depletion and generation of reactive
oxygen species that accompany PT have been
of caspase-3. Degradation of various cellular structures by caspase-3, by other downstream effector
caspases, and by other enzymes activated by caspase-3 lead to typical features of apoptosis, such as
internucleosomal DNA fragmentation.
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suggested to explain this caspase-independent
cell death (27). Endonuclease G, which is also
released from mitochondria, has been proposed
to account for the apoptosis-like chromatin
condensation in cells dying by caspase-
independent apoptosis (27).
Germ cell apoptosis
Physiological germ cell apoptosis
During prepubertal development, a wave of
extensive germ cell apoptosis is observed in the
rodent testis (53,54). This early germ cell
apoptosis, which mainly affects spermatogonia
and spermatocytes, appears to be essential for
functional spermatogenesis in adulthood. In the
adult testis also, normal spermatogenesis is
accompanied by spontaneous germ cell
degeneration, which appears to be mainly
apoptotic and to result in the loss of up to 75%
of the potential number of mature spermatozoa
(55-58). In the human testis, spontaneous germ
cell apoptosis involves all three classes of germ
cell, i.e. spermatogonia, spermatocytes, and
spermatids (58). However, the exact incidence
of adult male germ cell apoptosis is unclear,
because only the spermatogonia and round
spermatids display the classical morphological
and biochemical features of apoptosis (3).
Identification apoptotic spermatocytes and
elongated spermatids is less clear, because of
their unusual morphology and DNA
configuration (3).
The physiological significance of the
spontaneous germ cell apoptosis that occurs
during spermatogenesis is unclear. Since Sertoli
cells are terminally differentiated cells with no
capacity for renewal, and are able to support
only a certain number of germ cells, the number
of maturing germ cells must be limited (8).
Therefore, germ cell death, at least during
development, most likely occurs in order to limit
the number of germ cells to match the supportive
capacity of the Sertoli cells (3,53). Apoptosis
may also serve to eliminate germ cells with
altered DNA (53). In meiotic spermatocytes,
there appears to be a quality-control system or
checkpoint for monitoring chromosome
synapsis (59). This control system is thought
to recognize unrepaired double-strand DNA
breaks in unsynapsed chromosomes during
meiotic metaphase and to induce apoptosis of
the affected cell. Whether unrepaired DNA
breaks are the only inducers of apoptosis of
cells containing unsynapsed chromosomes is
not known. Surprisingly, the quality control-
induced apoptosis of meiotic germ cells appears
to be independent of p53, which is a major
regulator of apoptosis in response to DNA
damage in somatic cells and is strongly
expressed in pachytene spermatocytes (60).
Inappropriate germ cell apoptosis
Inappropriate male germ cell apoptosis is
associated with pathological conditions such
as infertility, cryptorchidism, and testis torsions
(53,61-65). Moreover, in rodents, increased germ
cell death has been shown to be induced in
vivo by external disturbances, such as
alterations of hormonal support, toxicant
exposure, or radiation (66-70). Consistently,
massive germ cell apoptosis occurs in vitro in
human seminiferous tubules cultured under
serum-free conditions, the apoptotic cells being
mainly pachytene spermatocytes and round
spermatids (71). Notably, in cultured rat
seminiferous tubules, apoptotic DNA
fragmentation is not found until 24 hours of
culture (72, our unpublished observations) but
in human seminiferous tubules is already
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evident after a few hours (71) indicating species
specificity in the sensitivity of testicular germ
cells to external death-inducing stimuli.
Defective spermatogenesis and male infertility
have been observed when expression of
apoptosis-related genes is disrupted or
inappropriately controlled (17,53,58,73). Thus,
high levels of the pro-apoptotic Bcl-2 family
members Bax and Bak in relation to the anti-
apoptotic Bcl-2 family members are associated
with germ cell apoptosis during development
and their imbalance results in infertility
(53,54,73). Moreover, the anti-apoptotic Bcl-2
family member Bcl-w appears to be an important
survival factor for Sertoli cells, spermatogonia,
and spermatocytes (74) and its deficiency leads
to increased postpubertal Sertoli and germ cell
death and consequent disruption of
spermatogenesis (75-77). Furthermore, the tumor
suppressor p53 is involved in radiation- and
cryptorchidism-induced mouse germ cell
apoptosis (78-80) and its overexpression in mice
results in increased germ cell apoptosis and
decreased production of spermatozoa (81). In
addition, mice with disruptions of various other
genes, including those encoding the
transcriptional activator CREM, the testis-
specific heat-shock protein HSP70-2, and
several other proteins involved in DNA repair
and cell-cycle control, exhibit defective
spermatogenesis and increased germ cell
apoptosis (17,58,82).
Hormonal control of germ cell
apoptosis
Gonadotropins and androgens
Gonadotropins and testosterone have been
shown to regulate testicular germ cell apoptosis
in a stage-specific manner (6,58). Thus, in the
immature rat, hypophysectomy or treatment with
gonadotropin-releasing hormone (GnRH)
antagonist results in increased germ cell
apoptosis, which can be inhibited by human
chorionic gonadotropin (hCG) or testosterone
(70,83). Apoptosis in the immature rat testis can
also be induced by immunoneutralization of FSH
(84). In the adult rat, gonadotropin withdrawal
by GnRH antagonist-treatment or
immunoneutralization of FSH appears to result
in increased germ cell apoptosis, mainly affecting
the pachytene spermatocytes and spermatids
(68,84,85). Consistently, in cultured adult rat
seminiferous tubules, apoptosis of pachytene
spermatocytes and spermatids can be inhibited
by FSH (72). Thus, rodent studies support an
anti-apoptotic role of gonadotropins in the
testis. However, in prepubertal boys with
cryptorchid testes, treatment with hCG results
in increased spermatogonial apoptosis (61). This
germ cell loss is associated with reduced testis
volume and lowered sperm counts in adulthood
(61).
The importance of testosterone in the regulation
of germ cell apoptosis in the adult rat testis has
been shown in experiments in which decreased
serum and intratesticular concentrations of
testosterone were caused by in vivo destruction
of Leydig cells (86,87). Testosterone withdrawal
induces apoptotic cell death in most stages of
the cycle and appears to mainly affect
spermatocytes and spermatids. These effects
can be suppressed by testosterone
supplementation (86). Interestingly however,
testosterone seems to be pro-apoptotic at one
stage of the cycle (86). Consistently with these
results of rodent studies, experiments conducted
in our laboratory have revealed that
testosterone is able to effectively inhibit in
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vitro-induced apoptosis of human
spermatocytes and spermatids and is thus a
germ cell survival factor also in the human testis
(71).
The mechanisms by which gonadotropins and
androgens regulate germ cell apoptosis are
unclear. The receptors for LH/hCG are expressed
in Leydig cells, which, under the influence of
LH, secrete testosterone (88). Furthermore, in
most studies the receptors for androgens have
been found in the Sertoli, peritubular myoid, and
Leydig cells, and those for FSH in the Sertoli
cells (88,89). Thus, according to these studies,
germ cells seem to be devoid of receptors for
gonadotropins and androgens, which suggests
that these hormones act by a paracrine
mechanism. The antiapoptotic effect of FSH
appears to be partially mediated via the stem
cell factor (SCF), which is produced by Sertoli
cells and interacts with the c-kit receptor on germ
cells (90). This mechanism may involve changes
in the Bcl-2 family members, since, in cultured
rat seminiferous tubules, either FSH or Sertoli
cell-derived SCF can up-regulate the anti-
apoptotic Bcl-w (54,74). The Bcl-2 family may
also contribute to the anti-apoptotic effect of
testosterone, as in vivo-induced testosterone
withdrawal and consequent germ cell apoptosis
in the rat is associated with down-regulation of
Bcl-w and up-regulation of pro-apoptotic Bax
and Bak (74,87). Importantly, testosterone can
be metabolized in vivo to either estrogens or
dihydrotestosterone (DHT), both of which may,
at least to some extent, mediate the pro-survival
effects of testosterone.
Estrogens
In addition to the established role of
gonadotropins and androgens in
spermatogenesis and testicular apoptosis,
estrogens are now recognized as potential
regulators of male reproduction and germ cell
death (91,92). Estrogens are formed from
testosterone by the enzyme P450 aromatase,
which is present in the Sertoli cells of the
immature testis and the Leydig cells of the adult
testis (92). In several species, P450 aromatase is
also expressed in the germ cells (92-95).
Estrogens can cause alterations in the
circulating concentrations of gonadotropins
and testosterone (92) and can thus affect germ
cell apoptosis indirectly. In addition to their
systemic effects, estrogens have specific direct
effects in the male reproductive tract. At least
some of these appear to be mediated by local
estrogen receptors (ERs), which exist in at least
two subtypes, ERα and ERβ. Testicular
expression of the ERs has been shown in
numerous recent reports, but the results
regarding their cellular localization are
controversial (92). Moreover, the expression
patterns of the ERs seem to be species specific
(92). In most studies, ERs have been found in
Sertoli and Leydig cells and in germ cells from
pachytene spermatocytes to round spermatids.
The subtype of ER in the seminiferous epithelium
has most often been found to be ERβ. In addition
to the conventional ERs, recent data suggest
the presence of a functional membrane-
associated ER on human spermatozoa, which,
when activated by 17β-estradiol, appears to
induce a nongenomic signaling pathway (96).
Direct evidence for a role of estrogens in male
germ cell survival has been obtained from
studies on mice deficient in functional ERα (ERα
knockout, ERαKO) (97,98), aromatase (ArKO)
(99), ERβ (ERβKO) (100), or both ERs (ERαβKO)
(101). The ERαKO males are infertile because of
impaired reabsorption of fluid in the efferent
ductules and resultant pressure-induced
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atrophy of the seminiferous epithelium (97,98).
Interestingly, the ArKO mice develop
progressive disruptions of spermatogenesis
and infertility, but they have no abnormal fluid
reabsorption in the efferent ductules(99).
Instead, the defective spermatogenesis in the
ArKO mice appears to be caused by a direct
effect of estrogen withdrawal on the
seminiferous epithelium and to involve
increased germ cell apoptosis (99). Somewhat
surprisingly, the ERβKO mice are fertile and have
no apparent disruption of spermatogenesis
(100). Moreover, the ERαβKO appear to have a
similar phenotype to ERαKO mice (101)
suggesting that ERβ does not play a major role
in the seminiferous epithelium.
In man, the importance of estrogens for normal
human spermatogenesis is suggested by case
reports of two men, one with a homozygous
inactivating mutation in the ERα gene (102) and
the other with the P-450 aromatase gene (103).
The patient with the mutation in the ERα gene
had normal male genitals and sperm density, but
sperm viability was severely decreased. The
mutation in the aromatase gene resulted in
infertility, with a decreased sperm count and
100% immotile spermatozoa. However, the exact
roles of estrogens in human spermatogenesis
have remained unknown.
Apoptosis control by the
death receptors Fas and
TNFR1
Death receptors and ligands
Death receptors are cellular receptors which,
after binding of specific death ligands, can
activate caspases within seconds and cause
apoptotic death of the cell within hours. Death
receptors belong to the large TNFR superfamily
(104,105). Members of this protein family are
characterized by similar cysteine-rich
extracellular domains. A subset of these
proteins, namely Fas (CD95/Apo-1), TNFR1
(p55/CD120a), death receptor 3 (DR3; TRAMP/
Apo3/WSL-1/LARD), TRAIL-R1 (DR4), TRAIL-
R2 (DR5/Killer/TRICK2), and DR6, contains an
intracellular “death domain” (DD), and is
therefore called the death receptor subfamily
(44,105). DD is an 80-amino-acid-long region that
is essential for transduction of the apoptotic
signal (32). The ligands that bind to the death
receptors are structurally related proteins that
belong to the TNF superfamily (44,105). These
include FasL (CD95L), TNFα, lymphotoxin α,
TWEAK (Apo3 ligand), and TRAIL (Apo2
ligand). The best-characterized death receptors/
ligands are Fas/FasL and TNFR1/TNFα.
Fas is a widely expressed glycosylated type I
transmembrane protein with a relative molecular
mass of approximately 45 to 52 kDa (106,107). In
addition, a soluble form generated by alternative
mRNA splicing may regulate Fas-mediated
apoptosis (108,109). The natural ligand for Fas
is FasL, which is a 40 kDa type II membrane
protein (110) that may also be cleaved by a
metalloproteinase to produce a soluble ligand
(111-113). FasL is expressed in a more restricted
way than Fas and is predominantly found in
activated lymphocytes and Natural Killer cells
(114). The testis is a major nonlymphoid site of
FasL expression (110,115).
TNFα has two receptors, TNFR1 (p55) and
TNFR2 (p75), of which only TNFR1 contains
the cytoplasmic DD and belongs to the family
of death receptors. TNFR1 is a transmembrane
receptor protein with a predicted molecular
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mass of approximately 45 kDa and, after
glycosylations, of 55 to 60 kDa (116). It is widely
expressed by somatic cells and can be cleaved
by matrix metalloproteinases to produce a
soluble receptor. TNFα, in turn, is a potent
cytokine that is produced by many cell types in
response to inflammation, infection, or injury
(117). The TNFα protein is formed as a 26 kDa
membrane-bound precursor, which is cleaved
by a metalloproteinase to generate the secreted
17 kDa mature cytokine (118,119).
Mechanisms for the regulation of
apoptosis by Fas and TNFR1
In death receptor-mediated apoptosis,
aggregation of the cellular death receptors with
their natural ligands or agonistic antibodies
activates the apoptotic death machinery in the
receptor-bearing cells (44,114,120). Each ligand
can bind three receptors, and trimerization is
most likely needed for transduction of the
apoptotic signal. Recently, another model has
been suggested, in which extracellular pre-
ligand-binding assembly domains (PLADs)
aggregate the receptors before ligand binding,
and premature signaling is prevented by
intracellular receptor-associated apoptosis
blockers (121,122). The intracellular DDs of the
aggregated receptors bind to specific signaling
molecules, which either link the receptors to the
apoptotic caspase pathway or, especially in the
case of TNFR1 activation, may mediate
functions that are distinct from or even
counteract apoptosis (Figure 3).
Fas activation (Figure 3) leads to association of
a complex of proteins, the death-inducing
signaling complex (DISC), with the activated
receptor (32,123). DISC involves FADD
(MORT1), which binds via its own DD to the
DD of Fas, and procaspase-8 (FLICE/MACH),
which is recruited by FADD via interaction of
death effector domains (DEDs) that are present
in both FADD and procaspase-8. Various other
proteins have also been said to bind to the
activated Fas and to DISC, but their role in the
regulation of Fas-mediated apoptosis remains
to be defined (32,124). Procaspase-8 is activated
proteolytically and released from the DISC into
the cytoplasm. As described above in the
paragraph “Apoptosis”, activation of caspase-
8 may, depending on the cell type (type I or II),
lead either to direct activation of the downstream
effector caspases or, more often, to amplification
of the signal by activation of the mitochondrial
pathway (27,31,32). Under some circumstances,
activation of a phosphorylation-based signaling
pathway involving a c-Jun amino-terminal kinase
(JNK) subgroup of a family of mitogen-activated
protein kinases (MAPKs) may contribute to
Fas-mediated apoptosis (125,126). Sustained
activation of JNK by Fas or by other stimuli
appears to be associated with apoptosis,
whereas transient JNK activation is usually
associated with the induction of survival
pathways (125,126). Thus, activation of JNK by
Fas may not only favor apoptosis, but may also
cause cellular events involved in adaptation to
stress (127). In some types of cell, Fas can also
induce an extracellular signal-regulated kinase
(ERK) subgroup of MAPKs that mediate cell
survival and protect from Fas-induced apoptosis
(128,129).
TNFR1 activation can also result in activation
of the caspase cascade leading to apoptosis
(Figure 3). However, TNFR1 also mediates
activation of transcription factors such as NF-
κB and AP-1, which can induce genes involved
in the suppression of apoptosis (Figure 3)
(44,45). Binding of TNFα to TNFR1 results in
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Fig. 3. Pro- and anti-apoptotic signaling pathways induced by Fas and TNFR1.  FasL or TNFα
binding to the death receptors Fas or TNFR1, respectively, results in receptor aggregation and
recruitment of adapter proteins. Both receptors transduce apoptotic signals through the
recruitment of FADD and subsequent recruitment and activation of procaspase-8. This is followed
by direct activation of caspase-3 (type I cells) or amplification of the signal in the mitochondria
(type II cells). Caspase-8 activation can be blocked by recruitment of the caspase-8-like inhibitory
protein c-FLIP. In some cell types, the JNK subgroup of MAPKs may mediate the death signal
from Fas, but the mechanism of Fas-induced JNK activation is not clear. TNFR1 recruits TRADD,
which binds the apoptosis-mediating FADD. TRADD also binds RIP1 and TRAF2, which mediate
activation of the transcription factors AP-1 and NF-κB through activation of the protein kinases
JNK, p38, and IKK. AP-1 and NF-κB are usually involved in cell survival, but, depending on the
cell type, may also mediate apoptosis. In some cell lines, both Fas and TNFR1 may activate
MAPK/ERK, which protect the cell from death receptor-induced apoptosis.
Abbreviations: TNFR1, tumor necrosis factor α receptor 1; FasL, Fas ligand; TNFα, tumor
necrosis factor α; DD, death domain; DED, death effector domain; FADD, Fas-associated
death domain protein; TRADD, TNFR1-associated death domain protein; JNK, c-Jun N-terminal
kinases; MAPK, mitogen mitogen-activated protein kinases; RIP1, receptor-interacting protein
1; TRAF2, TNF-receptor-associated factor 2; AP-1, activating protein-1; NF-kB, nuclear factor-
κB; p38, p38 kinase; IKK, IκB kinase; ERK, extracellular signal-regulated kinase; PT, permeability
transition; cyt c, cytochrome c.
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receptor trimerization and recruitment of a DD-
containing protein TRADD (TNFR1-associated
death domain protein). TRADD binds FADD via
the interaction of the DDs, which leads to
activation of the procaspase-8 as in Fas-
mediated signaling. However, TRADD also
binds at least two additional mediators, RIP1
(receptor-interacting protein 1) and TRAF2
(TNF-receptor-associated factor 2), which
stimulate pathways leading to activation of NF-
κB (via IκB kinase) and AP-1 (via JNK or p38
kinase subgroups of MAPKs). In addition,
TNFR1 may induce activation of MAPK/ERK
that protect from apoptosis (129). Fas does not
bind with high affinity to effector molecules
such as TRADD, RIP1, or TRAF2, and is
therefore a poor activator of NF-κB and AP-1
and more effective than TNFR1 for the induction
of apoptosis (45,124).
Physiological roles of the FasL-
and TNFα- induced signaling
FasL-induced signaling is suggested to play a
major role in several types of physiological
apoptosis (44,114,123,124,130). First, Fas
initiates activation-induced death of
lymphocytes, which is essential for down-
regulation of the immune reaction and protection
against autoimmunity. To downregulate the
immune reaction, activated T lymphocytes,
which express both Fas and FasL, either
undergo Fas-mediated suicide, or kill each other.
Loss-of-function mutations in the Fas or FasL
genes result in accumulation of mature T cells
in the lymph nodes and spleen of mice and
humans. Second, cytotoxic T lymphocytes
(CTL) and natural killer (NK) cells kill infected
cells via Fas-mediated apoptosis. When
activated through T cell-receptor interaction
with viral antigens, the cytotoxic cells start to
express FasL and kill the antigen-presenting
cells that express Fas. Inappropriate FasL-
mediated cytotoxic action of the CTL results in
tissue destruction such as occurs in hepatitis
and graft-vs-host disease. Third, killing of
inflammatory cells at immune-privileged sites
such as the eye and the testis has been
suggested to be mediated by the Fas system.
According to this model, stromal cells of the
immune-privileged tissues constitutively
express FasL, which kills Fas-expressing
inflammatory cells. Similarly, tumor cells have
been suggested to escape from the immune
system by expressing FasL. However, recent
studies have shown that FasL is expressed on
CTL after tumor recognition and that the CTL
are killed not by tumor cells but by themselves
and by neighboring CTL (131). The role of FasL
as a mediator of the immune-privileged nature
of the testis has also been questioned (131).
TNFα-induced signaling is involved not only
in apoptosis but also in inflammatory responses
and in cell proliferation and differentiation. The
primary sources of TNFα are activated
macrophages, but its production is also induced
in many other cell types in response to various
environmental factors (45,132). The major role
of TNFα is to provide protection against
infections and tumors (117,132). At the level of
the individual cell, TNFα may induce death of
an infected or transformed cell and, at the level
of multicellular organs and the whole organism,
it mediates inflammatory responses such as
lymphocyte and leukocyte activation and
migration, fever, and elevation of acute-phase
serum proteins (117,132,133). The broad
spectrum of the effects of TNFα is explained by
the ability of the TNF receptors to mediate the
activation of the transcription factors AP-1 and
NF-κB, which, in turn, commonly induce genes
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involved in inflammatory responses and cell
proliferation (43,45,134). AP-1 and, more
commonly, NF-κB can also induce genes
encoding proteins that mediate suppression of
TNFα-induced apoptosis. Thus, although
TNFα induces apoptosis in transformed or
infected cells, in normal  cells cell death is a rare
response to TNFα and usually occurs only when
gene expression is inhibited by RNA or protein
synthesis blockade (45,135-137).
The Fas system in the testis
The Fas system has been suggested to play a
role both in maintaining the immune-privileged
nature of the testis and in regulating testicular
germ cell apoptosis.  FasL has been found in
mouse, rat, and human Sertoli cells
(87,115,138,139) and is generally assumed to be
constitutively expressed by the Sertoli cells.
Some reports have shown FasL in germ cells
also (87,138). Fas expression, in turn, has been
demonstrated in the germ cells of the rat and
human testes (87,138,140), and in some reports
also in the Sertoli cells (87,138,141).
The idea of FasL as a mediator of testicular
immune-privilege is based on the finding that
testis grafts from normal mice survive when
transplanted under the kidney capsule of
allogenic animals, whereas testis grafts from
mice deficient in functional FasL are rejected
(115). FasL, which was found to be expressed in
the Sertoli cells of the normal mice, was
suggested to induce apoptosis of Fas-
expressing recipient T-cells activated in
response to graft antigens. This led to the
suggestion that expression of functional FasL
by Sertoli cells accounts for the immune-
privileged nature of the testis. However, this
concept will have to be re-evaluated, because,
in more recent studies, FasL expression on other
transplants caused inflammation and rapid
rejection instead of graft survival (131).
The role of the Fas system in testicular germ
cell apoptosis is supported by several findings
in rodent models. In the rat testis, the
expressions of both Fas and FasL are up-
regulated concomitantly with increased germ
cell apoptosis after exposure of the animals to
Sertoli cell toxicants (140). Furthermore, mouse
germ cells in vitro are susceptible to anti-Fas
antibody-induced death and the survival of
cultured rat germ cells is increased when the
expression of FasL is blocked by antisense
oligonucleotide treatment (140).  Radiation
exposure, which primarily targets the actively
dividing germ cells without causing damage to
the Sertoli cells, increases Fas but not FasL in
the rat testis (142). In contrast, exposure of rats
to Sertoli cell toxicants results in testicular up-
regulation of FasL, followed by up-regulation
of Fas (142). These results suggest that i) the
Fas system mediates testicular germ cell
apoptosis, ii) Fas up-regulation takes place at
the initiation of male germ cell death, and iii)
Sertoli cell injury causes up-regulation of FasL,
which eliminates Fas-positive germ cells.
However, there have been no studies concerning
the function of the Fas system in the human
testis.
Testicular production and effects
of TNFα
In the testis, TNFα is produced by the germ
cells and is held to be one of the testicular
paracrine factors that regulate spermatogenesis.
In mouse seminiferous tubules, TNFα is mainly
produced by the round spermatids (143). In
addition, activated interstitial macrophages of
the mouse and rat testis have been shown to
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secrete TNFα (144,145). TNFR1, in turn, has
been found in the Sertoli and Leydig cells of the
mouse and of the porcine testis (143,146-148).
Several effects of TNFα on these somatic cells
have been documented. In the Sertoli cells,
TNFα induces IL-6 production and adhesion
molecule expression (146,149,150). It has also
been suggested to play a role in the local control
of spermatogenesis, because in the Sertoli cells
it regulates the production of lactate (151,152),
transferrin (153), cAMP-response element-
binding protein (CREB) (154), and insulin-like
growth factor binding protein (IGFBP) (155). In
addition, cultured Leydig cells have been
shown to respond to TNFα by decreasing the
biosynthesis of testosterone (148,156,157).
In cultured mouse Sertoli cells, TNFα regulates
the expression and function of the Fas system,
suggesting a role for this cytokine in testicular
apoptosis (141). The cultured Sertoli cells
express low levels of functionally active
membrane-bound Fas protein, which are
markedly increased by stimulation with TNFα
(141). Therefore, inflammatory cytokines have
been suggested to create a proapoptotic
environment by inducing up-regulation of Fas
in Sertoli cells, which leads to Sertoli cell death
when contact occurs with FasL-bearing
inflammatory cells. On the other hand, TNFα, at
concentrations lower than those needed for
induction of the membrane-bound Fas, induces
a soluble anti-apoptotic form of Fas (141).
Therefore, in vivo TNFα produced by germ cells
may induce the soluble Fas, which is a potential
survival factor in the seminiferous tubules.
However, although studies on rodent Sertoli and
Leydig cells offer valuable information on the
possible roles of TNFα in regulating
spermatogenesis and testicular cell apoptosis,
the effects of this cytokine on maturing germ
cells has previously remained unknown.
Moreover, no previous reports have considered
the effects of TNFα on germ cell apoptosis in
the human testis.
Nuclear factor κB (NF-κB)
NF-κB/Rel and IκB proteins
NF-κB is a dimeric DNA sequence-specific
transcription factor which is assembled from two
of the five known mammalian Rel/NF-κB
proteins, i.e. RelA/p65, RelB, c-Rel, p50 and p52
(134). In most cells, the major Rel complex is the
p50-RelA heterodimer. In unstimulated cells, NF-
κB proteins remain sequestered in the cytoplasm
by inhibitory IκB proteins that include p105,
IκBγ, p100, IκBα, IκBβ, and IkBε (158,159).
These inhibitory proteins have different
affinities for individual NF-κB complexes, are
regulated differently, and are expressed in a
tissue- and cell-specific manner. The proteins
p105 and p100 are inactive precursor forms of
p50 and p52, respectively, and require post-
translational processing to produce the active
NF-κB subunits. IκBγ corresponds to the C-
terminal domain of p105. IκBα, IκBβ, and IkBε
bind to certain NF-κB complexes and prevent
nuclear translocation and DNA binding by
covering the nuclear localization sequence of
NF-κB and by interfering with sequences
important for DNA binding. In addition, there
exists a nuclear IκB protein, Bcl-3, which can
complex with specific NF-κB dimers and activate
κB-dependent transcription.
Activation and target genes of NF-
κB
NF-κB can be activated by a variety of
extracellular stimuli, including various microbial
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products, inflammatory cytokines, physical
stress, oxidative stress, mitogens, growth factors
and hormones, drugs, and hazardous
environmental compounds (43). Most signals
that lead to activation of NF-κB induce a
common pathway involving phosphorylation
and proteosome-mediated degradation of IκB
(Figure 4) (160). The key step in this pathway is
activation of a high-molecular-weight IκB kinase
(IKK) complex that contains two related catalytic
kinases, IKKα and IKKβ, and a regulatory
polypeptide IKKγ. When activated, the IKK
complex catalyzes the phosphorylation of two
conserved serines in the N-terminal regulatory
domain of IκBs. This is followed by
ubiquitination of the phospho-IκB, which
targets it for proteosomal degradation. The
liberated NF-κB then rapidly translocates into
the nucleus, where it regulates transcription by
binding to 10-base-pair DNA sites, i.e.
consensus κB sites, in the promoters of the
target genes (43).
NF-κB transcription factors bind κB sites as
dimers. Because the different NF-κB proteins
can form various homodimers or heterodimers
and the individual dimers have distinct DNA-
binding specificities, the NF-κB transcription
factors regulate a variety of genes (43). These
include genes encoding a number of cytokines
and their modulators, immunoreceptors,
proteins involved in antigen presentation, cell
adhesion molecules, acute phase proteins,
stress response proteins, cell-surface receptors,
growth factors, transcription factors, and
enzymes. Because NF-κB activity is induced
during various stress conditions and many of
the genes induced by NF-κB are involved in the
regulation of immune, inflammatory, and stress
responses, NF-κB is considered to be a central
regulator of stress responses. One of the genes
induced by NF-κB is that encoding IκBα, the
best known IκB protein. Newly synthesized IκBα
can enter the nucleus, remove NF-κB from the
DNA, and export the complex back into the
cytoplasm (Figure 4) (161,162). In this way, NF-
κB limits its own activation.
Despite the large number of genes that can be
induced by activated NF-κB, the response is
usually specific. This can be explained by i)
selective activation of NF-κB proteins, and ii)
the requirement of more than one transcription
Fig. 4. NF-κB activation. In unstimulated cells, NF-κB (the heterodimer of RelA and p50 in the figure) is
retained in the cytoplasm by inhibitory IκB (IκBα in the figure). Various NF-κB-inducing signals cause
activation of the IκB kinase complex (IKK). IKK phosphorylates IκB, which leads to its proteosomal degradation.
Liberated NF-κB translocates into the nucleus, where it binds to consensus κB sites in the promoters of the
target genes and regulates gene expression. One of the target genes of NF-κB is that encoding IκBα. The
newly synthesized IκBα may bind NF-κB in the cytoplasm or enter the nucleus, remove NF-κB from the DNA,
and export the complex back into the cytoplasm. In this way, NF-κB may limit its own activation.
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factor to induce effective transcription of a
given gene (43). Thus, the presence of different
NF-κB dimers, the synthesis and activation of
which may be controlled by distinct pathways,
increases the selectivity of the NF-κB-mediated
gene transcription. Moreover, NF-κB activity is
necessary but may not alone be sufficient for
the full transcription of certain genes, and thus
other transcription factors activated under
specific circumstances may also be required.
Regulation of apoptosis by NF-κB
NF-κB transcription factors may have both anti-
apoptotic and pro-apoptotic effects (40). The
anti-apoptotic activities of NF-κB have been
observed in certain non-testicular cells in
response to certain external stimuli, such as
TNFα, ionizing radiation, and chemotherapeutic
compounds (163-166). The inhibitory effect of
NF-κB on TNFα- or chemotherapy-induced
apoptosis has also been shown in
chemotherapy-resistant tumors (167). On the
other hand, there is growing evidence for the
apoptosis-promoting functions of NF-κB. In
human embryonic kidney cells, serum
withdrawal induces NF-κB activation and
apoptosis, which can be prevented by
overexpression of a dominant negative form of
RelA (168). Double-positive (CD4+CD8+) T cells
from mice overexpressing a superinhibitory
mutant form of IκBα are resistant to activation-
induced cell death (169). Furthermore, NF-κB
stimulates the expression of the death-
promoting FasL in T cells following T-cell
receptor engagement or exposure to DNA-
damaging agents, thus suggesting a pro-
apoptotic role for NF-κB (170,171). Interestingly,
a recent report suggested that during the onset
of inflammation, NF-κB activation is associated
with the expression of pro-inflammatory and
anti-apoptotic genes, whereas during resolution
of the inflammation, such activation is
associated with the expression of anti-
inflammatory genes and the induction of
apoptosis (172). Thus, at the onset of
carrageenin-induced pleurisy in the rat, in vivo
inhibition of NF-κB reduced leukocyte
expression of the pro-inflammatory cytokines
lymphotoxin B and TNFα and of the anti-
apoptotic protein Bcl-2. However, during
resolution of the inflammation, inhibition of NF-
κB resulted in down-regulation of pro-apoptotic
Bax and p53 and in concomitant inhibition of
leukocyte apoptosis. Finally, recent evidence
indicates that NF-κB may have either pro- or
anti-apoptotic effects in the same cell type,
depending on the death-inducing stimulus
(173). Taken together, whether NF-κB promotes
or inhibits apoptosis appears to depend on the
specific cell type and the type of the inducer.
Therefore, to understand the role of NF-κB in
different physiological situations, the behavior
of this transcription factor in different models
of apoptosis needs to be characterized.
NF-κB in the testis
Recent data have suggested a role for NF-κB in
regulating rodent spermatogenesis. In the rat
testis, the NF-κB complex of RelA and p50
proteins is constitutively expressed in the nuclei
of Sertoli cells at all stages of spermatogenesis,
but in some stages the expression is higher than
in others (174). In addition, nuclear NF-κB is
present in a stage-specific manner in pachytene
spermatocytes and round spermatids (174).
Moreover, in cultured rat Sertoli cells, an
increase in nuclear NF-κB DNA binding activity
and in κB-dependent transcription can be
induced by TNFα (174). As TNFα is known to
be secreted by round spermatids (143), a
paracrine mechanism has been suggested, in
which germ cell-derived TNFα modulates
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spermatogenesis by activating Sertoli cell NF-
κB (175). In accord, TNFα-induced activation
of NF-κB in rat Sertoli cells in vitro leads to up-
regulation of the cAMP-response element-
binding protein (CREB), which is an important
regulator of a number of cAMP-induced genes
and consequently has been suggested to be a
regulator of spermatogenesis (154). However,
the physiological role of NF-κB in the testis has
still remained unclear.
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Aims of the Study
Germ cell apoptosis is essential for normal spermatogenesis and its dysregulation may lead to
male infertility. Thus, understanding the causes and mechanisms of germ cell apoptosis is of major
importance in preventing male reproductive problems. Prior to the present study, knowledge on
the regulation of male germ cell apoptosis was mainly based on investigations conducted in
experimental animals. In view of species specificity of cellular responses to death-inducing stimuli,
a human model was also required. Such a model, in which germ cell apoptosis is induced in a
culture of human seminiferous tubules, was recently created in our study group.
The present series of studies aimed at characterizing the regulation of the initiating events in
human male germ cell apoptosis, using the culture of human seminiferous tubules. In particular,
elucidation of the following issues were addressed:
1. The effects of the physiological steroid hormones 17β-estradiol and DHT on male germ cell
death,
2. The roles of Fas- and TNFR1-mediated signaling and the closely related NF-κB activation
pathway in human testicular germ cell apoptosis,
3. The possibility of prevention of stress-induced apoptotic death of male germ cells by
pharmacological modulation of the apoptotic pathways characterized in the present studies.
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Patients
Testis tissue was obtained from 45 men aged 59
- 88 years undergoing orchidectomy as treatment
for prostate cancer. They had not received
hormonal, chemotherapeutic, or
radiotherapeutic treatment for the cancer before
the operation. They had no endocrinological
disease and none of them had suffered from
cryptorchidism. The operations were performed
between September 1997 and January 2001 at
the Department of Urology, Helsinki University
Central Hospital (Helsinki, Finland). The Ethics
Committees of the Hospital for Children and
Adolescents and the Department of Urology,
University of Helsinki, approved the study
protocol.
Tissue culture and treat-
ments
Apoptosis of the human testicular germ cells
was induced in vitro by incubating segments
of seminiferous tubules under serum-free
culture conditions. We cultured segments of
seminiferous tubules, rather than isolated germ
cells, in order to maintain the physiological
contacts between the Sertoli cells and the germ
cells. The testis tissue was microdissected on a
Petri dish containing tissue culture medium
(Nutrient mixture Ham’s F10, Gibco Europe,
Paisley, UK) supplemented with 0.1% human
albumin (Sigma Chemicals Co, St. Louis, MO)
and 10 µg/mL gentamicin (Gibco). Segments of
seminiferous tubules (~ 2 mm in length) were
isolated and transferred to culture plates
containing the same tissue culture medium and
cultured at 34°C in a humidified atmosphere
containing 5% CO2.
The effects of the following compounds on germ
cell apoptosis were studied by adding them to
the culture medium at the concentrations
indicated: 17β-estradiol (10-10, 10-9, and 10-7 M;
Sigma), ER antagonist ICI 182,780 (10-7 M; Tocris
Cookson Ltd., Bristol, UK), 5α-androstan-17β-
ol-3-one (DHT, 10-9, 10-8, and 10-7 M; Fluka
Chemie Ag, Buchs, Switzerland), anti-FasL
antibody sc-957/C-20 (1 and 20 µg/ml; Santa
Cruz Biotechnology, Santa Cruz, CA), caspase
inhibitor Z-VAD.FMK (2 and 20 µM; Enzyme
Systems, Dublin, CA), TNFα (1, 10, and 100 ng/
ml; Roche Molecular Biochemicals, Mannheim,
Germany or R&D Systems Ltd., Oxon, UK),
sulfasalazine (SS, 5 mM; Fluka Chemie Ag,
Buchs, Switzerland), acetyl salicylic acid (ASA,
5 mM; Sigma), N-acetyl-L-cysteine (NAC, 100
mM; Sigma), and NF-κB SN50 peptide (10 µg/
ml; Biomol Research Laboratories, Plymouth
Meeting, PA). Detailed descriptions of the use
of these compounds are given in the original
publications. In addition, the effects of sulindac
(1 mM; Sigma) and indomethacin (25 µM; Sigma)
were tested in experiments that were not
included in the original publications.
Laboratory analyses
Southern blot analysis of DNA
fragmentation
Genomic DNA was extracted from frozen
segments of human seminiferous tubules, using
the Apoptotic DNA Ladder Kit (Roche
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Molecular Biochemicals, Mannheim, Germany),
with some modifications. Briefly, the testis tissue
samples were homogenized with an Ultra-Turrax
T8 homogenizer and incubated for 10 min at
room temperature in binding/lysis buffer (6 M
guanidine-HCl, 10 mM urea, 10 mM Tris-HCl,
and 20% TritonX-100, pH 4.4). The samples
were then mixed with isopropanol (final conc.
25% v/v), loaded into polypropylene tubes, and
centrifuged for 1 min at 8000 rpm. The tubes
were washed twice with washing buffer (20 mM
NaCl and 2 mM Tris-HCl, pH 7.5), and the bound
DNA was eluted from the tubes with 10 mM
Tris, pH 8.5. Finally, the samples were incubated
with ribonuclease (2.5 µg/ml;
deoxyribonuclease-free ribonuclease, Roche)
for 20 min at room temperature. DNA was
quantified spectrophotometrically (absorbance
at 260 nm), and 1 µg of the DNA from each sample
was subjected to 3´-end-labeling with
digoxigenin-dideoxy-UTP (Dig-dd-UTP;
Roche) by the terminal transferase (Roche)
reaction. The DNA samples were then
electrophoresed on 2% agarose gels, blotted
onto nylon membranes, and crosslinked to the
membranes by UV irradiation. The membranes
were washed and blocked with 1% Blocking
reagent (Roche) in maleic acid buffer (100 mM
maleic acid, 150 mM NaCl, pH 7.5) for 30 min at
room temperature. The 3´-end labeled DNA on
the membranes was localized with alkaline
phosphatase-conjugated anti-digoxigenin
antibody (Anti-Digoxigenin-AP; Roche), and
the bound antibody was detected by the
chemiluminescence reaction (CSPD; Roche).
In situ end labeling (ISEL) of
apoptotic DNA
Small segments of human seminiferous tubules
(~1 mm in length) were squashed on microscope
slides under coverslips to produce a monolayer
of cells, and the preparations were fixed as
previously described (176), with some
modifications. Briefly, the slides were frozen in
liquid nitrogen, after which the coverslips were
removed and the frozen slides were dipped in
ice-cold ethanol. The preparations were then
fixed in 4% formalin for 10 min, washed in PBS,
incubated in ice-cold ethanol:acetic acid (2:1)
for 5 min, washed in distilled water, dehydrated,
and stored at -20ºC. For ISEL, the squash
preparations were first rehydrated, then washed
in distilled water, and microwaved at high power
for 5 min in citrate buffer (10 mM citrate, pH 6.0).
After incubation for 10 min with terminal
transferase reaction buffer (1 M potassium
cacodylate, 125 mM Tris-HCl, and 1.25 mg/ml
BSA, pH 6.6), the apoptotic DNA was 3´-end
labeled with Dig-dd-UTP (Roche) for 1 h at 37°C
by the terminal transferase reaction. For the
negative controls, the terminal transferase
enzyme was replaced with the same volume of
distilled water. The preparations were then
blocked with blocking solution (2% Blocking
reagent, Roche, in 150 mM NaCl, 100 mM Tris-
HCl, pH 7.5), followed by location of the Dig-
dd-UTP with either alkaline phosphatase-
conjugated (in the original publication II) or
peroxidase-conjugated (in the original
publications I, III, and IV) antidigoxigenin
antibody (Anti-Digoxigenin-AP or Anti-
Digoxigenin-POD, Roche). For detection of the
antibodies, substrates for alkaline phosphatase
(NBT, X-phosphate; Roche) or peroxidase
(0.05% diaminobenzidine; Sigma) were added.
Light counterstaining was performed with
hematoxylin, after which the samples were
dehydrated and mounted.
 Electron microscopy
Segments of seminiferous tubules were fixed in
2.5% glutaraldehyde in 0.1 M phosphate buffer,
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dehydrated, and embedded in epoxy resin. The
samples were then sectioned at 50 nm with a
Reichert E Ultramicrotome (Reichert Jung,
Vienna, Austria) and stained with uranyl acetate
and lead citrate. The samples were examined
with a Jeol JEM 1200 EX transmission electron
microscope (Jeol, Tokyo, Japan).
Immunohistochemistry
Immunostainings of the ERα, ERβ, Fas, TNFR1,
TNFR2, NF-κB RelA (p65), or NF-κB p50
proteins were performed on sections of formalin-
fixed, paraffin-embedded adult human testis
tissue or isolated seminiferous tubules, or on
squash preparations of human seminiferous
tubules. Paraffin sections were incubated at 60°C
for 30 min and deparaffinized in xylene. Both
paraffin sections and squash preparations were
then rehydrated, microwaved at high power for
5 min in citrate buffer (10 mM citrate, pH 6.0) for
antigen retrieval, washed, and blocked with
blocking solution (PBS containing 5% goat
normal serum, 3% BSA, and 0.1% Tween 20) for
at least 30 min at room temperature. Our
preliminary experiments revealed that unspecific
staining for endogenous peroxidases only
occurred in the erythrocytes of the testicular
capillaries found in paraffin sections of testis
tissue, and therefore, endogenous peroxidases
were usually not blocked. The proteins under
investigation were detected with the following
antibodies: ERα HC-20 (sc-543, Santa Cruz), ERα
NCL-ER-6F11 (Novocastra Laboratories Ltd.,
Newcastle, UK), ERα ER-1D5 (DAKO Corp. A/
S, Glostrup, Denmark), ERβ PAI-313 (Affinity
BioReagents, Inc., Golden, CO), Fas C-20 (sc-
715, Santa Cruz), TNFR1 H-271 (sc-7895, Santa
Cruz), TNFR1 CSA-810 (StressGen
Biotechnologies Corp., Victoria, Canada),
TNFR2 H-202 (sc-7862, Santa Cruz), NF-κB RelA
(sc-109, Santa Cruz), or NF-κB p50 (sc-7178X,
Santa Cruz). The optimal concentrations and
incubation conditions for these antibodies are
described in the original publications. The
primary antibodies were detected using biotin-
conjugated secondary IgGs from the
corresponding ABC-Elite kits (Vector
Laboratories, Inc., Burlingame, CA), followed
by incubation with ABC solution. For location
of the secondary antibody, 0.05%
diaminobenzidine substrate (Sigma) was added.
For the negative controls, the primary
antibodies were replaced with nonspecific rabbit
IgG (Sigma). Double immunostaining of the
TNF-R1 and a macrophage surface antigen was
performed, using the polyclonal TNFR1 H-271
antibody and a monoclonal antibody to the
human macrophage surface antigen (HAM56,
DAKO Corp. A/S, Glostrup, Denmark) as
described in “Subjects and Methods” of III.
After the staining protocols, light
counterstaining was performed with
hematoxylin, and the samples were dehydrated
and mounted.
Protein extractions
For whole cell protein extracts, sections of testis
tissue or segments of cultured seminiferous
tubules were homogenized with an Ultra-Turrax
T8 homogenizer into ice-cold homogenization
buffer (1% Triton X-100, 150 mM NaCl, 10 mM
Tris pH 7.4, 1 mM EDTA, 1 mM EGTA, 0.2 mM
PMSF, 1 µg/ml leupeptin). The homogenates
were vortexed vigorously, incubated on ice for
20 min, and centrifuged at 17,000g for 30 min.
The resultant supernatants were used as whole
cell protein extracts. For cytoplasmic and nuclear
protein extracts, segments of seminiferous
tubules were gently homogenized with a tight-
fitting Potter-Elvehjem homogenizer into ice-
cold hypotonic buffer (50 mM HEPES, pH 7.4,
10 mM KCl, 1 mM EDTA, 1 mM DTT, 0.2 mM
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PMSF, 1 µg/ml pepstatin A, 1 µg/ml leupeptin,
0.5% Nonidet P-40), and cytoplasmic and
nuclear protein extracts were prepared as
previously described (177). Protein
concentrations were determined by the Bradford
method, using the Bio-Rad DC protein assay
(Bio-Rad Laboratories, Hercules, CA). The
protein extracts were stored in aliquots at -80°C
until used for Western blotting or electrophoretic
mobility shift assays.
Western blotting
Western blottings of the ERα, ERβ, Fas, FasL,
TNFR1, TNFR2, and IκBα were performed on
whole cell or cytoplasmic testicular protein
extracts. Defined aliquots of proteins were
loaded into SDS-polyacrylamide gels and
electrophoresis was performed at 150 - 180 V.
The proteins were electroblotted onto
polyvinylidene difluoride (PVDF) membranes
(Immobilon-P, Millipore Corporation, Bedford,
MA) and the transfer was checked by staining
with 0.2% Ponceau S in 3% trichloroacetic acid.
The proteins examined on the membranes were
detected using the following antibodies: ERα
HC-20 (sc-543, Santa Cruz), ERα H-184 (sc-7207,
Santa Cruz), ERβ PAI-313 (Affinity
BioReagents), Fas C-20 (sc-715, Santa Cruz),
FasL (F37720, Transduction Laboratories,
Lexington, KY), TNFR1 H-271 (sc-7895, Santa
Cruz), TNFR1 CSA-810 (StressGen), TNFR2 H-
202 (sc-7862, Santa Cruz), or IκBα (sc-371 and
sc-847; Santa Cruz). The concentrations and
incubation conditions for these antibodies are
detailed in the original publications. When
possible, the specificity of the bands detected
with the antibodies was confirmed by
preabsorption experiments. The primary
antibodies were followed with peroxidase-
conjugated goat anti-rabbit IgG (Jackson
ImmunoResearch Laboratories, West Grove, PA)
or peroxidase-conjugated goat anti-mouse IgG
(DAKO Corp. A/S, Glostrup, Denmark). The
bound secondary antibody was located with
the ECL detection Kit (Amersham Pharmacia
Biotech, Uppsala, Sweden). After detection of
the protein under investigation, the membrane
was, on most occasions, washed and, as a
loading control, probed with an antibody to α-
tubulin (Sigma).
Electrophoretic mobility shift
assay (EMSA)
A DNA probe containing a consensus κB
enhancer element (5´-AGT TGA GGG GAC TTT
CCC AGG C-3´) was purchased from Santa Cruz
(sc-2505, Santa Cruz Biotechnology, Inc., Santa
Cruz, CA). The probe was 5´-end-labeled with
[γ-32P]ATP, using T4 polynucleotide kinase
(Promega Corporation, Madison, WI). Testicular
nuclear protein extracts (10 µg) or control nuclear
protein extracts (Jurkat T cells, Santa Cruz, sc-
2132; KNRK cells, Santa Cruz, sc-2141; K562
cells, Santa Cruz, sc-2130; and LPS-stimulated
human monocyte-derived macrophages, kindly
provided by Dr Jukka Hakala, Wihuri Research
Institute, Helsinki, Finland) (5-10 µg) were
incubated on ice for 10 min with 2 µg poly(dI-
dC)(dI-dC) (Amersham Pharmacia Biotech) in
50 mM HEPES (pH 7.6), 10% glycerol (vol./vol.),
225 mM KCl, 1 mM EDTA, 2.5 mM DTT, 1 mM
MgCl2, 0.75 mM PMSF and 1.5 µM leupeptin. A
5´-end-labeled probe (15 000 – 30 000 cpm) was
then added, and incubation was continued at
room temperature for 30 min. In the competition
experiments, a 100-fold molar excess of
unlabeled probe or unlabeled mutated probe
(sc-2511, Santa Cruz) was added before the
labeled probe. Reaction products were
separated at room temperature on 4%
polyacrylamide gels run in 22.5 mM Tris-borate,
and 0.5 mM EDTA at 200 V. After
Materials and Methods
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electrophoresis, the gels were dried and
visualized by autoradiography. In the supershift
assays, 2 µg of affinity-purified polyclonal
antibodies were added after binding reactions,
and incubation was further continued for 1 hour
at room temperature. The antibodies for the
supershift assays were purchased from Santa
Cruz (RelA/p65, sc-109X; p50, sc-7178X; c-Rel,
sc-272X; p52, sc-298X; RelB, sc-226X).
Quantitative analysis of x-
ray films
The x-ray films exposed to chemiluminescense
(Southern blots, Western blots) or
autoradiography (EMSAs) were scanned with
a tabletop scanner and the digital image was
analyzed with the Gel plot 2 macro for the
National Institutes of Health-Image 1.61
(Bethesda, MD, USA) (original publication II)
or Scion Image beta 4.0.2 (Scion Corporation,
Frederick, MD) (I, III, IV) image analysis
software. For the Southern blots, the digitized
quantification of the low-molecular-weight DNA
fragments (< 1.3 kB) in the sample cultured for
4h or 5 h (or 10 h in time-course analysis of
nuclear apoptosis; Figure 9, Figure 2 in IV)
without treatments was taken as 1.0 (100%
apoptosis), and the amounts of low-molecular-
weight DNA fragments in the other samples
were expressed in relation to this. For studies
on alterations in the protein expression of the
Fas and FasL (III), standard curves for Fas, FasL,
and α-tubulin were generated with a dilution
series of a control sample. The amounts of Fas
or FasL in the samples were expressed in relation
to the amount of α-tubulin in the corresponding
samples. For time-course analysis of NF-κB
activation (Figure 9, Figure 2 in IV), the digitized
quantification of the specific NF-κB bands in
the sample cultured for 5 h was set as 1.0, and
the intensities of the bands in the other samples
were expressed in relation to this.
Statistics
The experiments for Southern blot analysis of
the effects of the tested compounds on
apoptotic DNA fragmentation were repeated on
at least three independent occasions.
Quantitative data represent low molecular
weight DNA (integrated optical density from
scanned x-ray films). In the original publications
I, III, and IV, data (mean ± SEM) were analyzed
by one-way ANOVA, and when, significant
differences were found, this was followed by
comparison of the groups with a two-tailed
unpaired Student’s t test. P < 0.05 was
considered statistically significant. Data
demonstrating the time-courses of IκBα
degradation, NF-κB DNA-binding activity, or
nuclear apoptosis in IV are representative of
two independent experiments. At least three
independent experiments were conducted when
alterations in the expressions of ERα, ERβ, Fas,
or FasL were studied by Western blotting. At
least three independent experiments were also
conducted in which the effects of sulfasalazine,
ASA, NAC, or SN-50 on NF-κB DNA binding
activity were studied by EMSA or in which the
effect of sulfasalazine on IκBα expression was
studied by Western blotting. The effects of both
sulindac and indomethacin were evaluated in
two independent experiments. Each
immunohistochemical picture or Western blot
demonstrating the expression of a certain protein
is representative of at least three independent
experiments.
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In vitro induction of human
male germ cell apoptosis
In the present in vitro model, human germ cells
were cultured in their natural surroundings, i.e.
in the seminiferous tubules, to maintain as
physiological an environment as possible. Germ
cell apoptosis was induced in this model by
incubating segments of seminiferous tubules
under serum-free culture conditions. Southern
blot analysis of apoptotic DNA fragmentation
Results
Fig. 5. In vitro induction of human male germ cell apoptosis. Segments of seminiferous
tubules were cultured under serum-free conditions to induce germ cell apoptosis. A. Southern
blot analysis of low-molecular-weight (MW) DNA fragmentation (185 bp multiples). DNA was
extracted from the seminiferous tubules cultured for various periods of time, after which 1 µg of
the total DNA in each sample was 3´-end labeled with Dig-dd-UTP, electrophoresed, and
blotted onto a nylon membrane. The labeled DNA on the membrane was detected with
chemiluminescence as described in “Materials and Methods”.  B. ISEL analysis of the induction
of germ cell apoptosis. Uncultured (0 h) and cultured (4 h) segments of seminiferous tubules
were squashed and fixed, and apoptotic DNA fragments were detected by 3´-end labeling with
Dig-dd-UTP as described in “Materials and Methods”. Very rare ISEL-positive cells (dark nuclei)
were observed in uncultured tubule segments, whereas in samples cultured for 4 to 5 hours in
apoptosis-inducing conditions, the number of ISEL-positive cells was greatly increased. Original
magnification, x200. C. Electron micrographs of normal and late apoptotic pachytene
spermatocytes and spermatids. For electron microscopy, segments of seminiferous tubules
were fixed, sectioned at 70 nm, and stained as described in “Materials and Methods”. Bars: 2
mm.
in cultured segments of seminiferous tubules
was used as the basic method for detecting
testicular apoptosis. Apoptotic DNA
fragmentation was observed within 4 to 5 hours
and was further increased between 10 and 48
hours of culture. The time course of apoptotic
DNA fragmentation from 0 to 10 hours is
presented in Figure 5A.
In situ end-labeling (ISEL) of apoptotic DNA in
squash preparations of uncultured and cultured
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segments of seminiferous tubules (Figure 5B,
Figure 4 in I, Figure 3 in II, Figure 2 in III, and
Figure 4 in IV) was performed to confirm the
results of Southern blotting, to identify the
apoptotic cells, and to obtain information on
the tissue morphology after culture. We used
squash preparations rather than paraffin
sections because (i) on account of the lack of
false-positive labeling, which may occur after
accidental formation of free DNA 3´-ends during
permeabilization of paraffin sections, we
considered the results of ISEL more reliable, and
because (ii) in squash preparations, the nuclei
of the cells maintain their characteristic
morphology better, allowing more accurate
identification of the individual cell types.
Consistent with Southern blots, the number of
ISEL-positive cells increased during culture.
The cells undergoing apoptosis were found to
be mainly premeiotic spermatocytes and
postmeiotic spermatids.
The apoptotic nature of the cell death and the
identification of the degenerating cells were
further confirmed by electron microscopy
(Figure 5C, Figure 1 in II), using the
morphological criteria of apoptosis and the
characteristic morphology of different germ cell
types. Typical signs of the apoptotic cells were,
for example, condensation of nuclear chromatin,
degeneration of cytoplasmic organelles, and, in
the later stages of apoptosis, dispersion of the
nuclear envelope. The morphological signs of
apoptosis were seen most often in
spermatocytes and spermatids. Some of the
apoptotic spermatids showed a ring-like
condensation of chromatin around the nuclear
periphery, which is characteristic of apoptosis
in this type of germ cell. Late apoptotic cells
were impossible to identify.
Effects of 17β-estradiol and
dihydrotestosterone on
male germ cell apoptosis
Inhibition of germ cell apoptosis
by 17β-estradiol
To evaluate the effects of estrogens on male
germ cells, we studied the role of the natural
estrogen, 17β-estradiol, in germ cell apoptosis
in the present culture model. Interestingly, 17β-
estradiol effectively inhibited in vitro-induced
germ cell death (Figure 6, Figure 3 in I). The
most effective concentrations were 10-10 and
10-9 M, which are in the range of the previously
reported physiological 17β-estradiol
concentrations in human spermatic vein and
testis tissue (178-181). In Southern blot analysis,
the total amounts of low-molecular-weight DNA
fragmentation were suppressed by 47% (P <
0.001) and 41% (P < 0.01) at 17β-estradiol
concentrations of 10-10 and 10-9 M, respectively.
A higher 17β-estradiol concentration of 10-7 M
did not significantly inhibit germ cell death.
Thus, it appears that 17β-estradiol prevents
germ cell death at its physiological, but not
higher, concentrations. Similarly, physiological,
but not higher, concentrations of testosterone
have previously been shown to prevent germ
cell apoptosis in the present culture model (71).
The suppressive effect of 17β-estradiol on germ
cell apoptosis was blocked by the ER antagonist
ICI 182,780 at 10-7 M (Figure 3 in I). ISEL of
squash preparations from seminiferous tubules
isolated immediately after orchidectomy (0 h) or
cultured in serum-free conditions in the
presence or absence of 17β-estradiol also
indicated a clear inhibitory effect of 17β-
estradiol on germ cell death (Figure 4 in I).
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Expression of ERα and ERβ in the
adult human seminiferous
epithelium
Since the antiapoptotic action of 17β-estradiol
may take place via activation of ERs, the
locations of the ERα and ERβ proteins in the
human seminiferous epithelium were studied in
squash preparations of seminiferous tubules,
using a rabbit polyclonal antibody (HC-20) and
mouse monoclonal antibodies (ER-6F11 and ER-
1D5) to human ERα and a rabbit polyclonal
antibody to human ERβ. Strong positive staining
for the ERα protein was observed in early meiotic
germ cells (zygotene and early pachytene
spermatocytes) and in early elongating
spermatids (Figure 1 in I). Whether we used the
polyclonal (HC-20) or the monoclonal (ER-6F11
or ER-1D5) antibodies to ERα, the result was
the same (not shown). Of note, ERα
immunoreactivity was located in the cytoplasm
and/or the plasma membrane. The specificity of
the staining with the HC-20 antibody was
confirmed by preabsorption experiments with
the corresponding peptide. The ERβ protein was
found to be expressed by the same types of
germ cells as the ERα (Figure 1 in I). ERβ
immunoreactivity was found both in the nuclei
and in the cytoplasm. Finally, Western blot
analysis indicated the expression of both ERα
and ERβ in the human seminiferous tubules
(Figure 2 in I) and thus agreed with the results
of immunohistochemistry.
Effect of DHT on in vitro-induced
germ cell apoptosis
Testosterone, which inhibits germ cell apoptosis
in the present model (71), can be metabolized in
vivo to either 17β-estradiol or DHT. We therefore
studied the effects of not only 17β-estradiol but
also DHT on the in vitro-induced apoptotic
death of testicular germ cells. DHT was also
found to inhibit testicular apoptosis (Figure 6,
Figure 5 in I). However, the lowest
concentrations of DHT needed for effective
inhibition of germ cell death were 100-1000 times
the effective concentrations of 17β-estradiol,
indicating the relatively high potency of
Fig. 6. Inhibition of male germ cell
apoptosis by 17β-estradiol and DHT.
Segments of seminiferous tubules were
cultured for 4 hours under serum-free
conditions in the absence or presence of 17β-
estradiol or DHT. DNA was extracted from
the seminiferous tubules and equal aliquots
(1µg) of the total DNA in each sample were
3´-end labeled with Dig-dd-UTP. The aliquots
were electrophoresed, subjected to Southern
blotting, and analyzed with
chemiluminescence, as described in
“Materials and Methods”.  Low-molecular-
weight (MW) DNA (<1.3 kB) fragmentation
was quantified from x-ray films exposed to
chemiluminescence. The digitized
quantification of the low MW DNA fragments
in the samples cultured in the absence of
steroids was taken as 100% apoptosis, and the amounts of low MW DNA fragments in the other samples
were expressed in relation to this. Each value represents the mean ± SEM of the indicated number of
independent experiments.
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estrogens as germ cell survival factors compared
with that of androgens (Figure 6). Apoptotic
low-molecular-weight DNA fragmentation was
suppressed by 38% at a DHT concentration of
10-7 M (P < 0.05). Lower concentrations of DHT
did not significantly inhibit germ cell death.
Regulation of germ cell
apoptosis by the Fas
system
Expression of Fas and FasL in the
human testis
Localization of the Fas protein in the human
seminiferous epithelium was studied
immunohistochemically, using rabbit polyclonal
antibody to human Fas. In squash preparations
of uncultured segments of seminiferous tubules,
strong positive staining for the Fas protein was
found in spermatocytes and round spermatids,
i.e. in the same cell types that underwent
apoptosis in the cultured seminiferous tubules
(Table 1, Figure 2 in II). The expressions of both
Fas and FasL during germ cell apoptosis were
then assessed by Western blot analysis of
human seminiferous tubules cultured under
serum-free conditions for increasing lengths of
time. The expression of Fas remained constant
at 0, 4, and 24 h (Figure 6 in II). In contrast, the
expression of FasL was markedly up-regulated
after 4 hours of culture (Figure 6 in III).
Inhibition of germ cell apoptosis
by the antibody to FasL or by
caspase inhibitor Z-VAD. FMK
To study the functional role of the Fas system
in human germ cell apoptosis, we used the
polyclonal anti-FasL antibody to inhibit
apoptotic cell death in the culture of
seminiferous tubules. This antibody binds to
the carboxyl terminal part of the FasL, thus
preventing interaction between Fas and FasL
(182). Addition of this antibody to the culture
caused clear inhibition of germ cell death when
analyzed both by ISEL (Figure 3 in II) and by
Southern blotting (Figure 7, Figure 4 in II). The
anti-FasL antibody reduced the total amount of
low-molecular-weight DNA fragmentation by
39% at a concentration of 20 µg/ml. Lower
concentrations of the antibody were not
effective. Because the downstream effectors of
Fas include various caspases, we next tested
the ability of a universal inhibitor of caspases,
Z-VAD.FMK, to block germ cell apoptosis and
found that it inhibited germ cell death (Figure 7,
Figure 5 in II). DNA fragmentation was
suppressed by 35% and 45% at the Z-VAD.FMK
concentrations of 2 µM and 20 µM, respectively.
Thus, in the present in vitro-model, Fas-FasL
signaling appears to be involved in the initiation
of germ cell apoptosis. Furthermore, this Fas-
associated germ cell death is likely to be
mediated by caspases.
Effects of TNFα on germ
cell death and on the Fas
system in cultured human
seminiferous tubules
TNFR expression in the human
testis
The presence of TNFR1 and TNFR2 in the
human testis was first studied by Western
blotting, and both receptors were detected
(Figure 4 in III). However, by
immunohistochemistry, specific staining was
found only for TNFR1. The TNFR1 was detected
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by two different antibodies in the Sertoli cells
and interstitial Leydig cells (Table 1, Figure 5 in
III). In the Sertoli cells, two kinds of staining
were observed: i) a diffuse staining in the nuclei
or in close proximity to the nuclei and ii) a
spotted staining that was seen overall in the
seminiferous epithelium and may represent
cytosolic or plasma membrane staining of the
Sertoli cells. Notably, no spotted staining was
present in the neighboring peritubular myoid
cells, which argues against the nonspecific
nature of this staining pattern. In the
immunoreactive interstitial cells, the staining
was found in the cytoplasm. These cells were
obviously Leydig cells, since they lacked the
macrophage marker HAM56. Some clusters of
TNFR1-expressing spermatogonia and
pachytene spermatocytes were also found
(Table 1), but these cells were far more rare than
the immunoreactive Sertoli cells.
Inhibition of male germ cell
apoptosis by TNFα
To evaluate the role of TNFα in germ cell
apoptosis, we added recombinant human TNFα
to the culture medium and studied its effects on
the amount of apoptosis after culture for 4 hours
in serum-free conditions. Interestingly, TNFα
inhibited germ cell death effectively and dose-
dependently (Figure 7, Figure 1 in III). In
Southern blot analyses, the total amount of low-
molecular-weight DNA fragmentation was
suppressed by 25% (P < 0.001) and 43% (P <
0.001) at TNFα concentrations of 10 ng/ml and
100 ng/ml, respectively. A TNFα concentration
of 1 ng/ml was also tested in three experiments,
but it did not significantly inhibit germ cell death.
ISEL of squash preparations from seminiferous
tubules isolated immediately after orchidectomy
(0 h) or cultured for 4 hours under serum-free
conditions in the absence or presence of TNFα
confirmed the results of Southern blotting
(Figure 2 in III).
Because TNFα-induced survival is often
associated with activation of the NF-κB
pathway, we tested the ability of TNFα to
increase the NF-κB DNA-binding activity in the
present culture conditions. EMSAs of
seminiferous tubules cultured for 0, 1, or 4 h
under serum-free conditions indicated that NF-
κB DNA-binding activity strongly increased
during culture. However, TNFα did not affect
this NF-κB activation (Figure 4 in III).
Down-regulation of the Fas ligand
by TNFα
To study whether changes in the function of
the Fas system could contribute to the observed
anti-apoptotic effect of TNFα, the expressions
of Fas and FasL were studied by Western blot
analysis of seminiferous tubules cultured under
serum-free conditions in the absence or
presence of TNFα. We found that the expression
of the Fas protein in the seminiferous tubules
was not affected by TNFα (not shown).
However, concomitantly with inhibiting
Table 1. Expression of the death receptors Fas and TNFR1 in human seminiferous epithelium.
The expression of Fas and TNFR1 was assessed by immunohistochemistry, using rabbit polyclonal antibodies
to human Fas or TNFR1 as described in “Materials and Methods”. Fas expression was studied in squash
preparations of uncultured segments of seminiferous tubules and TNFR1 expression was studied in
sections of formalin-fixed and paraffin-embedded uncultured human testis tissue.
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testicular apoptosis, TNFα was found to regulate
the expression of the FasL (Figure 8, Figure 6 in
III). In five independent experiments, the
expression of the FasL in tubules cultured under
serum-free conditions for 4 hours was up-
regulated by 48 – 185 % as compared with
tubules that were not subjected to apoptosis-
Fig. 7. Effects of modulation of the Fas- and
TNFR1-mediated signaling pathways on male
germ cell apoptosis in vitro . Segments of
seminiferous tubules were cultured for 4 hours
under serum-free conditions in the absence or
presence of FasL blocking antibody C-20 (20 µg/
ml), caspase inhibitor Z-VAD.FMK (20 µM), or
recombinant human TNFα (100 ng/ml). Southern blot
analysis of low-molecular-weight (MW) DNA (<1.3
kB) fragments in the tubule segments and
quantification of the data were performed as
described in “Materials and Methods”. The digitized
quantification of the low MW DNA fragments in the
samples cultured in the absence of any treatment
was taken as 100% apoptosis and the amount of
low MW DNA fragments in samples treated with
anti-FasL antibody, Z-VAD.FMK, or TNFα were
expressed in relation to this. Each value represents the mean ± SEM of the indicated number of independent
experiments.
Fig. 8. Down-regulation of the testicular FasL by TNFα. Protein extracts from seminiferous tubules
cultured for 0 and 4 hours under serum-free conditions in the absence or presence of 100 ng/ml TNFα were
electrophoresed on 12% polyacrylamide gels, and analyzed by Western blotting as described in “Materials
and Methods”. FasL expression was quantified from Western blots and adjusted to the expression of α-
tubulin, which was used as a loading control. In each experiment, the expression of the FasL was up-
regulated in the tubules that were exposed to apoptosis-inducing conditions. This up-regulated expression
of the FasL was decreased by TNFα.
inducing conditions. TNFα decreased this up-
regulated FasL expression by 14 - 72 %. The
results were adjusted for the amount of α-
tubulin present in the samples.
NF-κB activation in human
testicular cell apoptosis
Constitutive NF-κB activity in the
adult human testis
To explore the constitutive NF-κB activity in
the adult human testis, the DNA binding
activity of the κB-binding proteins was first
studied by EMSAs, using nuclear protein
extracts from uncultured human seminiferous
tubules and a DNA probe containing a
consensus κB-binding sequence. Three DNA-
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protein complexes designated A, B, and C
(Figure 1A in IV) were found. Band B was clearly
seen, while bands A and C were poorly visible
in the basal situation before exposure of the
seminiferous tubules to apoptosis-inducing
conditions. Competition experiments confirmed
the specificity of the binding to the κB
oligonucleotide (Figure 2 in IV). As
demonstrated by the supershift assay, the NF-
κB subunits RelA (p65) and p50 participated in
the formation of the observed DNA-protein
complexes (Figure 1A in IV).
Immunohistochemical studies using polyclonal
antibodies to human RelA and p50 proteins were
then conducted on sections of paraffin-
embedded, formalin-fixed human testis tissue
to determine the cell types expressing
constitutively active NF-κB (Table 2, Figure 1B
in IV). In the majority of the tubules, strong
positive staining for RelA was found in the
cytoplasm of some spermatogonia and early
meiotic spermatocytes. In contrast, nuclear
localization of the RelA, indicating expression
of the active DNA binding protein, was
observed in only a few scattered tubules. The
cells showing positive nuclear immunostaining
were identified as Sertoli cells. Because of the
large volume of Sertoli cell cytoplasm and its
partial rupture during sample preparation, direct
comparison between Sertoli cell cytoplasmic and
Sertoli cell nuclear or germ cell cytoplasmic
staining is difficult. Thus, the light
immunostaining that was observed around the
Sertoli cell nuclei and germ cells most likely
represents cytoplasmic expression of RelA in
the Sertoli cells. A similar staining pattern was
observed with an antibody against p50 (not
shown). When the primary antibody was
replaced with nonspecific rabbit IgG, no specific
staining was found (negative control, shown in
Figure 4 in IV).
Induction of testicular NF-κB
during culture of human
seminiferous tubules
The activation of NF-κB during testicular cell
apoptosis was studied, using culture of human
seminiferous tubules. Apoptotic DNA
fragmentation was observed in cultured
segments of seminiferous tubules within 5 hours
and was further increased at 10 hours of culture
(Figure 9, Figure 2A in IV). In the same tubules,
NF-κB DNA binding activity had strongly and
rapidly (within 30 min) increased from the basal
level and remained at this elevated level
throughout the culture for 10 hours (Figure 9,
Figure 2B in IV). In EMSA, the intensity of band
A especially was markedly strengthened during
induction of testicular cell apoptosis. Western
blot analysis of IκBα protein in the seminiferous
tubules showed that, in agreement with the rapid
increase in NF-κB DNA-binding activity, IκBα
was readily degraded after withdrawal of serum
(Figure 6A in IV). We therefore concluded that
NF-κB activation occurs very early as compared
with nuclear apoptosis (Figure 9, Figure 2C in
IV).
EMSA supershift assays, using nuclear protein
extracts from seminiferous tubules cultured for
2.5 hours in serum-free conditions, indicated
that the inducible NF-κB complexes A and B are
composed of the p50 and RelA subunits (Figure
3 in IV). Nuclear translocation of the p50 and
RelA proteins was then studied
immunohistochemically in sections of paraffin-
embedded, formalin-fixed human seminiferous
tubules. In all the segments of tubules cultured
for 2.5 or 5 hours in serum-free conditions,
nuclear translocation of RelA and p50 proteins
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was observed in Sertoli cells, indicating that the
site of NF-κB activation was the Sertoli cells
(Table 2). Of note, nuclear translocation of the
NF-κB proteins was not observed in the
spermatogonia or in the early meiotic
spermatocytes, in which cytoplasmic staining
for RelA and p50 was intense in the 0 h samples
(Table 2). Since the presence and the nuclear
translocation of RelA and p50 were similar, only
the RelA immunostaining is shown in Figure 4
of IV.
Fig. 9. Time-course of activation of the
transcription factor NF-κB during germ cell
apoptosis. Segments of seminiferous tubules
were cultured under serum-free conditions for the
indicated periods of time, after which apoptotic low-
molecular-weight (MW) DNA (<1.3 kB)
fragmentation was studied by Southern blotting and
NF-κB DNA binding activity was studied by
electrophoretic mobility shift assays (EMSAs) and
quantified as described in “Materials and Methods”.
For Southern blots, the digitized quantification of
the low MW DNA fragments in the sample cultured
for 10 hours was taken as 100% apoptosis, and
the amounts of low MW DNA fragments in the other
samples were expressed in relation to this. For EMSAs, the digitized quantification of the specific NF-κB
bands in the sample cultured for 5 hours was set as 100%, and the intensities of the bands in the other
samples were expressed in relation to this. The results shown are representative of two independent
experiments.
Table 2. Cellular localization of NF-κB immunostaining and ISEL positivity (apoptotic DNA
fragments). Constitutive NF-κB expression in human seminiferous epithelium was assessed by
immunostaining the RelA and p50 NF-κB subunits in paraffin-embedded, formalin-fixed sections of testis
tissue or in squash preparations of uncultured segments of seminiferous tubules, using polyclonal antibodies
to the corresponding human proteins, as described in “Materials and Methods”. Cellular localization of the
inducible nuclear NF-κB expression and ISEL positivity were studied in formalin-fixed, paraffin-embedded
sections or squash preparations of segments of seminiferous tubules cultured for 2.5 and 5 h under
serum-free conditions. Nuclear expression of the NF-κB proteins usually indicates that they are active.
Thus, NF-κB activation appears to occur in Sertoli cells, whereas apoptotic DNA fragmentation takes place
predominantly in spermatocytes and spermatids.
When considering the potential role of NF-κB
in the regulation of apoptosis in the testis, it
was of interest to determine whether NF-κB
activation occurred in the cell types undergoing
apoptosis. Therefore, we performed RelA
immunostainining and ISEL of squash
preparations of human seminiferous tubules that
had not been exposed to apoptosis-inducing
conditions, or that had been cultured in serum-
free conditions to induce apoptotic cell death
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(Table 2, Figure 4B in IV). In agreement with the
results in the paraffin sections, nuclear
translocation of RelA was observed in the
Sertoli cells. In contrast, in the ISEL analysis,
apoptotic DNA fragmentation was
predominantly observed in the late meiotic and
postmeiotic germ cells, whereas the Sertoli cell
nuclei remained negative. Thus, NF-κB
activation was induced in the Sertoli cells, while
apoptotic cell death occurred in germ cells.
Effects of anti-inflammatory
and NF-κB inhibitory
compounds on stress-
induced male germ cell
apoptosis
Fas activation, TNFα-mediated signaling, and
NF-κB-induced gene expression have all been
found to be associated with immune and
inflammatory responses. Therefore, we tested
the ability of previously reported anti-
inflammatory and NF-κB inhibitory compounds
to modulate apoptotic germ cell death in our in
vitro model.
Sulfasalazine
Both germ cell apoptosis and NF-κB induction
were effectively blocked by the anti-
inflammatory drug sulfasalazine (Table 3, Figure
5 in IV). During 5 hours of culture, a 5 mM
concentration of sulfasalazine (SS) inhibited
apoptotic DNA fragmentation by 87% (P <
0.001) and concomitantly retained NF-κB DNA
binding activity at the basal (0 h) level after 2.5
hours and 5 hours. In two independent
experiments, effective inhibition of apoptotic
DNA fragmentation by sulfasalazine was still
observed after 48 hours of culture (not shown).
Suppression of germ cell death was also
observed in ISEL of seminiferous tubules
cultured in the absence or presence of
sulfasalazine. After the treatment, no severe
abnormalities were seen in the morphology of
the cells of the seminiferous epithelium.
As sulfasalazine has previously been reported
to inhibit NF-κB activity in certain cell types by
inhibiting IκB degradation (183,184), we wished
to know whether the same inhibitory mechanism
would function in the seminiferous epithelium.
Although Western blot analysis of cultured
seminiferous tubules showed that the IκBα
protein was degraded, it did not completely
disappear; the lowest level was observed at 2.5
h, after which the expression of IκBα gradually
increased slightly (Figure 6A in IV). This is likely
to be explained by the known ability of activated
NF-κB to stimulate transcription of the IκBα
gene. IκBα degradation was not prevented in
the samples treated with 5 mM sulfasalazine
(Figure 6A in IV), suggesting that sulfasalazine
inhibits NF-κB activation at a level distal to that
of IκB degradation. In contrast, in sulfasalazine-
treated tubules after 5 hours of culture, Western
blotting revealed the complete disappearance
of the IκBα protein, suggesting that
sulfasalazine prevented the NF-κB-induced
synthesis of new IκBα protein. In agreement
with the results of the IκBα Western blots, RelA
immunostaining of sulfasalazine-treated
seminiferous tubules showed that nuclear
translocation of the RelA protein in the Sertoli
cells was not prevented by sulfasalazine (Figure
6B in IV). Thus, in this apoptosis model,
sulfasalazine seemed to inhibit NF-κB DNA
binding in the nucleus.
Finally, as the promoter of the gene encoding
FasL is known to contain NF-κB binding sites
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(171,185), and as the regulation of this gene has
been suggested to be a potential target for NF-
κB in the testis (175), we tested the effect of the
sulfasalazine-mediated NF-κB blockade on the
expression of the FasL protein in Western blot
analysis. Despite the effective inhibition of NF-
κB activation, sulfasalazine had no effect on the
protein expression of the FasL after culture for
2.5 h and 5 h (not shown), suggesting that NF-
κB does not regulate testicular FasL expression
during stress-induced apoptosis.
Other compounds
A NF-κB inhibitory peptide SN-50 (10 µg/mL),
which interferes with the nuclear translocation
of activated NF-κB dimers, slightly inhibited
testicular apoptosis (24%, P = 0.01), but an
inhibitory effect of this peptide on NF-κB
activation could not be reliably detected with
EMSAs (Table 3). Other previously reported NF-
κB inhibitors, acetyl salicylic acid (ASA) and N-
acetyl-L-cysteine (NAC), were found to be
effective inhibitors of germ cell apoptosis (Table
Table 3. Effects of anti-inflammatory and NF-κB inhibitory compounds on seminiferous tubule
NF-kB DNA-binding activity and germ cell apoptosis. Segments of seminiferous tubules were cultured
under serum-free conditions in the absence or presence of 5 mM sulfasalazine, 5 mM acetyl salicylic acid,
100 mM N-acetyl-L-cysteine, 10 µg/mL NF-kB SN50 peptide, 1 mM sulindac, or 25 µM indomethacin. After
culture for 2.5 hours, samples of the tubules were snap-frozen and the nuclear proteins were prepared for
analysis of NF-κB activity. The rest of the tubules were cultured for 5 hours and analyzed for apoptotic
DNA fragmentation. NF-κB DNA binding activity was analyzed by EMSAs and apoptotic DNA fragmentation
by Southern blotting, as described in “Materials and Methods”.
3, Figure 5A in IV). Apoptotic DNA
fragmentation was reduced by 44% (P < 0.05)
with ASA at 5 mM and by 87% (P = 0.001) with
NAC at 100 mM. ISEL analysis confirmed the
results of Southern blotting and showed that
the overall morphology of the testicular cells
was normal after the treatments with ASA and
with NAC (Figure 5C in IV). However, although
capable of inhibiting apoptosis, ASA and NAC
had no effect on NF-κB DNA binding (Table 3,
Figure 5B in IV). In addition, the effects on
testicular NF-κB DNA binding and apoptosis
of two other anti-inflammatory drugs, sulindac
(1 mM), which inhibits NF-κB in some cell lines
(186), and indomethasin (25 µM), which should
not affect NF-κB (187), were tested in two
independent experiments. Both compounds
inhibited apoptotic cell death, but did not affect
NF-κB DNA binding (Table 3). Thus, the anti-
apoptotic effects of ASA, NAC, sulindac, and
indomethasin appear to be mediated by
mechanisms other than NF-κB inhibition.
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Discussion
The present study aimed at elucidating the
regulation of human testicular apoptosis, using
cultured human seminiferous tubules as a model
of apoptosis. In this model, the steroid
hormones 17β-estradiol and DHT at their
physiological concentrations were found to
suppress germ cell death. Unexpectedly, 17β-
estradiol appeared to be an even more potent
inhibitor of testicular apoptosis than the non-
aromatizable androgen DHT. The studies were
then focused on the signaling pathways
initiated by FasL and by TNFα, the cytokines
known as “death factors”. It was found that i)
human testicular germ cell apoptosis is mediated
by the Fas system, ii) TNFα protects male germ
cells from apoptotic death and opposes the Fas
system by down-regulating the FasL, and iii)
the transcription factor NF-κB, which is often
considered to be a mediator of TNFα-induced
survival signals, appears not to mediate the
antiapoptotic effect of TNFα, but to function in
parallel with or downstream of the Fas pathway
to regulate human testicular germ cell apoptosis.
Finally, as the Fas and TNF systems, as well as
NF-κB, are mediators of human inflammatory
responses, the ability of anti-inflammatory
compounds to inhibit testicular apoptosis was
studied. Interestingly, common anti-
inflammatory drugs were found to effectively
inhibit germ cell apoptosis, raising the
possibility that they could be used
therapeutically in transient stress situations
involving excessive germ cell death and
consequent male infertility.
Methodological aspects
In the present study, we used an in vitro tissue
culture for investigating the regulation of
human testicular cell apoptosis. Our culture
model, like all in vitro models, has limitations.
Activation of specific apoptotic pathways
depends on the type of stressor, and the culture
of seminiferous tubules under serum-free
conditions involves not only deprivation of
serum and growth-factors, but also relative
hyperoxia due to the high partial oxygen
pressure in the normal atmosphere as compared
with that found in peripheral organs such as
the testis. Thus, the apoptotic pathways
induced in the present model are potentially
multiple and there may also be multiple inducers
of a specific pathway. Moreover, various stimuli
may differentially activate certain pathways in
different types of testicular cells. Therefore,
mechanistic and inhibitory studies of specific
apoptotic pathways are difficult to conduct in
the present model. It would be interesting to
study the Fas system, TNFα-mediated
signaling, or NF-κB activity following either
specific Sertoli cell toxicants (66,69) or disturbers
of germ cells such as radiation (79,188). However,
the culture conditions are difficult to optimize
so that no germ cell apoptosis occurs, which is
a prerequisite for the conduction of such
experiments. Culturing isolated cells, in turn, is
inappropriate, because interactions between
different types of seminiferous epithelial cells
play an important role in testicular physiology
and pathology. In support of this, maturation of
isolated germ cells from spermatogonial stem
cells to the meiotic prophase has not been
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achieved in any published study in vitro (2). It
appears that both the initiation of
spermatogonial differentiation from stem cells
and the entry of differentiating spermatogonia
into meiosis are blocked in a culture of isolated
cells. Moreover, Sertoli cells have been shown
to inhibit apoptosis of spermatocytes and round
spermatids in in vitro culture conditions (189),
supporting the need of a culture model that
maintains cell-to-cell contacts when studying
the regulation of germ cell apoptosis.
Furthermore, in vivo studies with apoptosis-
modulating treatments are virtually impossible
in humans. Finally, because of the potential
species specificity of cellular responses, results
obtained in animal studies do not necessarily
apply to humans. Therefore, we feel that, despite
its limitations, the present in vitro model, which
maintains physiological contacts between the
cells of the seminiferous epithelium, affords the
best available way to evaluate human testicular
apoptotic mechanisms involving interactions
between different cell types. The present culture
system models a situation in which human
testicular homeostasis is threatened,
demonstrates how different types of cells in the
seminiferous epithelium may act during severe
stress, and affords an opportunity to study the
effects of pharmacological modulation of stress-
induced apoptosis in the human testis.
For our experiments, we used testis tissue
samples from men undergoing orchidectomy as
treatment for prostate cancer. The testis tissue
in these patients was normal and was removed
in order to stop physiological production of
hormones that stimulate the growth of the
cancer cells. Despite the old age of most of these
patients, germ cells at all phases of maturation
were found in light microscopic and electron
microscopic evaluation of the tissue. Samples
from younger men were only available as
testicular biopsies that were taken because of
infertility or suspected disease or as testis tissue
that was removed because of testicular cancer.
In all these cases, the samples were either too
small for our experiments or were disturbed by
disease. Therefore, we considered the
orchidectomy samples appropriate and the best
available samples for the present studies on
human testicular apoptosis.
17β-estradiol as a survival
factor for male germ cells
Estrogens have recently been shown to be
essential for male reproduction (97,99,190), but
the exact roles of estrogen in spermatogenesis
have remained unclear. In the present study, we
demonstrate that, in addition to the previously
suggested indirect effects of estrogens on the
seminiferous epithelium, estrogens may
contribute directly to the survival of germ cells
in the testis. Interestingly, we found that the in
vitro-induced apoptosis of male germ cells was
effectively inhibited when 17β-estradiol was
added to the culture medium. As only
seminiferous tubules and some occasional
interstitial Leydig cells, but not other parts of
the testis, were present in our culture model,
this action of 17β-estradiol must be a direct effect
either on the cells of the seminiferous tubules
or on the Leydig cells. Although estrogens
have a well-documented inhibitory effect on
Leydig cell androgen secretion and RNA
synthesis, the concentrations of 17β-estradiol
needed for in vitro inhibition of Leydig cell
function in the previous studies (191-194) were
at least 1000-fold the concentrations capable of
effectively inhibiting germ cell apoptosis in the
present study. Therefore, the possible inhibitory
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effect of these low apoptosis-inhibiting
concentrations of 17β-estradiol on the
occasional Leydig cells present in our culture
model and consequent indirect effects of 17β-
estradiol on germ cell survival seem unlikely.
The suppressive effect of 17β-estradiol on germ
cell apoptosis was blocked by an ER antagonist,
ICI 182,780, suggesting that the effects of 17β-
estradiol were mediated by some types of ERs.
The classic ER signaling pathway involves
binding of the ligand-bound ER to the estrogen-
responsive element that regulates transcription
of target genes in the nucleus. ERs may also
regulate gene transcription by binding to
proteins within a preformed transcriptional
complex, such as the AP1 transcription factor
complex (92,195). In addition to the regulation
of gene transcription by ligand-bound nuclear
ERs (nERs), recent studies have revealed
evidence for the existence of functional plasma
membrane estrogen receptors (pmERs) (196-
198). These receptors may share structural
similarities with classical nERs, for a variety of
antibodies directed against multiple epitopes of
the nuclear ERα identify a membrane protein in
several cell types (197). In response to 17β-
estradiol, pmERs induce rapid signaling events
such as activation of phosphoinositol 3-kinase,
protein kinase B/Akt, and ERK and p38 MAP
kinases. Moreover, it is possible that the large
cytosolic pool of ERs, envisioned as a reservoir
before it moves to the nucleus, can in fact act
on cytosolic organelles. Indeed, it has been
suggested that, as an anti-apoptotic factor,
cytosolic estradiol-ER complexes may locally
regulate mitochondrial membrane potential
(197,199). Thus, it appears that 17β-estradiol can
interact with distinct, compartmentalized pools
of receptors, each having unique effects on
cellular physiology and possibly also on cell
survival. As in the present study the
antiapoptotic effect of 17β-estradiol on germ
cells was seen after incubation for 4 h, it is
possible that the survival of germ cells is
mediated at least partly by rapid signaling
pathways induced by the non-nuclear ERs.
Our finding that both the ERα and ERβ proteins
are expressed in early meiotic and postmeiotic
germ cells of the human testis suggests direct
effects of 17β-estradiol on these cells.
Antibodies against ERα protein reacted with a
cytoplasmic and/or plasma membrane protein,
which supports a role for extranuclear (plasma
membrane or cytosolic) ERs in 17β-estradiol-
mediated germ cell survival. In the cells staining
positively for ERβ, immunoreactivity was found
both in the nuclei and in the cytoplasm. The
presence of ERβ protein in testicular germ cells
is in accord with the previously reported
expression pattern of ERβ mRNA in the human
testis (200). The presence of ERα, however, has
been found only in rat spermatocytes and
spermatids in one study (201), whereas in other
studies on testicular ER expression, neither ERα
mRNA nor protein has been detected in germ
cells (92). In our study, we confirmed the results
obtained with the polyclonal ERα antibody with
two widely used and well-characterized
monoclonal antibodies to human ERα (202).
Moreover, we followed standard
immunohistochemical protocols. Therefore, the
discrepancy between the results is most likely
caused by differences in the samples used in
immunohistochemistry. We detected the ERs in
squash preparations of human seminiferous
tubules, which have not been used in any of
the other studies. We decided to use squash
preparations because the literature on ER
expression in samples of other types is highly
controversial (92), and because in the squash
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preparations the cells of the seminiferous
epithelium maintain their morphology better
than in frozen or paraffin sections of the human
testis. Since our results obtained with these
preparations differ from the results of most
previous studies, the human testicular
expression of the ERα or an extranuclear ERα-
like ER remains to be confirmed. If only ERβ,
and no ERα or other ERs, is expressed in
testicular germ cells and possibly also in Sertoli
cells (92), the lack of any spermatogenic
disruptions in ERβKO mice is surprising.
Interestingly, a recent study showed that
testicular germ cells from ERαKO mice could
develop normally when transplanted into wild-
type mice, suggesting that germ cells do not
require ERα expression for development and
function (203). Accordingly, the roles of germ
cell ERα, ERβ, and other types of ER  as
mediators of the anti-apoptotic effect of 17β-
estradiol remains to be clarified. Moreover, the
possible contribution of Sertoli cells to 17β-
estradiol-mediated germ cell survival remains
unknown.
In the previous experiments conducted by our
study group, testosterone was shown to be an
effective inhibitor of germ cell apoptosis in the
human testis in vitro (71). However, the
concentrations of testosterone (10-7 M) required
for this apoptosis-inhibiting effect were 100-
1000 times the effective concentrations of 17β-
estradiol (10-9-10-10 M). Of note, the effective
concentrations of testosterone and 17β-estradiol
are in the range of their relative physiological
levels in the spermatic vein (178,179,181,204,205)
and in testis tissue (180,206). In vivo,
testosterone can be metabolized to either
estrogens or DHT. We found that DHT was also
capable of inhibiting germ cell death in our in
vitro model, but, like testosterone, its lowest
effective concentrations were strikingly higher
than the effective concentrations of 17β-
estradiol. Thus, in vitro 17β-estradiol appears
to be a more potent inhibitor of male germ cell
death than the androgens testosterone and DHT.
The essential role of androgens in completing
normal spermatogenesis is well established.
However, the mechanism by which androgens
regulate spermatogenesis has not been resolved,
and even the site of androgen action within the
testis has remained unclear. Some reports have
shown an immunoreactive androgen receptor
(AR) in developing germ cells (207-210), but
most suggest that only testicular somatic cells
contain AR (89,211-214). If the germ cells lack
functional AR, the effects of androgens on
spermatogenesis may be mediated by the
somatic cells. The results of the present study
suggest another interesting mechanism for
testosterone-mediated survival of germ cells.
Taken the present result that 17β-estradiol is
much more potent than androgens in inhibiting
germ cell apoptosis and the previously reported
expression of P450 aromatase by adult Leydig
and germ cells in several species (93-95,215-217),
it is possible that, to mediate its protective
effects on germ cells, testosterone is at least to
some extent metabolized to estrogen. This
hypothesis is supported by the results from mice
lacking aromatase (ArKO), which were found
to have increased germ cell apoptosis in the
adult testis (99). The AR-mediated action of
androgens, in turn, is needed for normal
development of male reproductive organs, as
indicated by the phenotype of human 46,XY
individuals with the androgen insensitivity
syndrome, which is caused by the absence or
abnormality of the AR (218-220). In complete
androgen resistance, the patients have a female
body habitus, female external genitalia, and
bilateral, undescended testes with abnormal
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morphology and progressive reduction in the
number of germ cells with increasing age. Thus,
AR-mediated androgen effects appear to be
indispensable for testicular development,
whereas estrogens are possibly needed for the
testosterone-mediated survival of germ cells in
the adult testis.
Taken together, our results strongly suggest
that estrogens act as germ cell survival factors
in the human testis. This effect of estrogens
may be mediated through conventional ERs, but
signaling by a nonclassical ER or via a
nongenomic pathway is also possible. The
present results, together with the results of
studies on ERαKO (97,98) and ArKO (99) mice,
indicate the importance of estrogens for the
normal function of the adult testis.
Fas- and TNFR1-mediated
signaling in the regulation
of human male germ cell
death
The closely related signaling pathways initiated
by the cytokines FasL and TNFα were of
interest to us, because they are known to
mediate apoptosis in many cell types and they
have both been suggested to play a role in the
regulation of spermatogenesis. Fas had
previously been shown to induce apoptosis in
the rodent testis, but human studies were not
available. TNFα had been shown to be secreted
by testicular germ cells and to have some effects
on cultured Sertoli and Leydig cells, but the
effects of this cytokine on maturing germ cells
was unknown and its role in the regulation of
spermatogenesis was unclear.
In the present study, the Fas system was found
to mediate germ cell apoptosis in cultured human
seminiferous tubules (Figure 10). Fas was
expressed in pachytene spermatocytes and
round spermatids, which are the same types of
cells that underwent apoptosis in the present
culture model. Moreover, germ cell death was
inhibited by blocking the interaction between
Fas and FasL. These results are in agreement
with the rodent data showing that Fas activation
plays a role in mouse and rat testicular apoptosis
(140,142). However, although Fas is up-regulated
after many treatments that induce massive germ
cell apoptosis in the rodent testis (140,142), we
did not observe increased expression of the Fas
protein during culture of the seminiferous
tubules. In contrast, up-regulation of testicular
FasL was associated with germ cell apoptosis
suggesting that, in cultured human seminiferous
tubules, increased germ cell death is at least
partly  caused by elevated levels of FasL. In the
rodent testis, it appears that injury of germ cells
results in up-regulated Fas, whereas injury of
Sertoli cells triggers increased production of
FasL (142). In the present study, however, the
Sertoli cells were usually not injured and
survived. Thus, the results of rodent studies
do not seem to apply to the human germ cell
apoptosis induced in the present culture model.
This may be explained by the different apoptosis
models or may indicate species specificity in
the regulation of the Fas system.
In contrast to FasL, TNFα was found to
suppress testicular germ cell death (Figure 10).
This effect of TNFα appears to result from
TNFR1 activation, because only TNFR1 was
found by immunohistochemistry in the
uncultured human testis. Within the
seminiferous epithelium, occasional germ cells
stained positively for TNFR1, which may
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indicate a direct effect of TNFα in these cells.
However, the most abundant expression of the
TNFRI was seen in the Sertoli cells. In these
cells, two kinds of staining were observed; a
diffuse staining located more or less in the
nucleus and a spotted staining located in the
cytoplasm or the plasma membrane. Although
TNFR1 is traditionally regarded as a cell surface
receptor, recent reports have shown that the
Golgi apparatus is a major site of TNFR1
expression, and in some cell types, such as
endothelial cells, TNFR1 is primarily a Golgi-
associated protein, only a minor subpopulation
of receptors being present in the plasma
membrane (221-223). The Golgi-associated
TNFR1 has been shown to have a perinuclear
immunostaining pattern. Moreover,
phosphorylation of the TNFR1 by extracellular
signal-regulated kinase p42mapk/erk2 leads to
redistribution of the phosphorylated receptor
from the Golgi apparatus and plasma membrane
to perinuclear tubular structures that are
associated with the endoplasmic reticulum (221).
Thus, the nuclear TNFR1 staining pattern found
in the human Sertoli cells may represent TNFR1
in either the Golgi apparatus or the endoplasmic
reticulum-associated tubular structures. The
spotted staining, in turn, is likely to represent a
receptor population located in the Sertoli cell
plasma membrane, since in the plasma
membrane, TNFR1 is associated with lipid rafts,
which have been shown to exhibit this kind of
staining pattern (224). The physiological
significance of the alterations in the subcellular
localization of the TNFR1 is unclear, although
they apparently lead to changes in the signaling
properties of the receptor (224,225). Thus, in
the endoplasmic reticulum, phosphorylated
TNFR1 recruits Bcl-2 and phosphorylation-
induced redistribution of the TNFR1 protects
against apoptosis by a Bcl-2-dependent
mechanism (225). It is also possible that the
Golgi apparatus, known to be strongly enriched
in unesterified cholesterol, a major component
of lipid rafts, is a storage site for TNFR1, from
which the receptor can be translocated to the
lipid rafts on the plasma membrane upon
appropriate stimuli (224).
The predominant expression of the TNFR1 in
the Sertoli cells suggests a paracrine mechanism
for the TNFα-induced survival of germ cells.
Interestingly, suppression of germ cell death by
TNFα was associated with decreased testicular
expression of FasL. Down-regulation of the
death-promoting FasL may therefore mediate the
survival signal induced by TNFα (Figure 10). A
similar mechanism of TNFα-mediated inhibition
of apoptosis was observed in the vascular
endothelium, where down-regulation of FasL
expression in the endothelial cells by TNFα led
to decreased endothelial cytotoxicity toward
Fas-bearing leukocytes (226). However, the
mechanism by which TNFα-induced signaling
may affect the expression of FasL remains
unclear. In cell types resistant to pro-apoptotic
signals of TNFα, the survival signals induced
by this cytokine are often associated with
activation of the NF-κB pathway (40,135,137).
Moreover, the promoter of the gene encoding
FasL is known to contain NF-κB binding sites
(171,185), suggesting that NF-κB is a potential
regulator of FasL. In the present study, NF-κB
DNA binding activity was increased in
seminiferous tubules cultured under serum-free
conditions and showing increased apoptosis.
However, TNFα appeared to have no effect on
this NF-κB activation, suggesting that, in the
human testis, TNFα may induce down-
regulation of the testicular FasL and germ cell
survival via a pathway distinct from NF-κB
activation.
52
Discussion
NF-κB in male germ cell
apoptosis
NF-κB is an interesting candidate for regulation
of male germ cell apoptosis, for there is growing
evidence that this transcription factor has a
function in cell proliferation and apoptosis, and
recent studies suggest a role for NF-κB in
mammalian spermatogenesis. Moreover, the
surprising finding that NF-κB was strongly
activated during in vitro-induced testicular
apoptosis, but that this activation did not appear
to be associated with the TNFα-induced germ
cell survival, prompted us to undertake a further
investigation of NF-κB activity in the normal
human testis and its role in testis tissue
undergoing apoptosis.
Consistently with the results for the rat testis
(174), we found low basal NF-κB DNA binding
activity, which, by immunostaining of the RelA
and p50 subunits, was localized to the Sertoli
cells. However, in contrast to the rat testis, in
which Sertoli cells express nuclear NF-κB at all
stages of spermatogenesis (174), in the human
testis only a few segments of the seminiferous
tubules contained Sertoli cell nuclei that were
immunoreactive. Moreover, we found no germ
cells showing nuclear NF-κB, which contrasts
with the previously observed stage-dependent
expression of nuclear NF-κB in the late meiotic
and postmeiotic germ cells of the rat testis (174).
However, intense cytoplasmic staining for NF-
κB was found in the spermatogonia and early
meiotic germ cells of the human testis. As no
nuclear translocation of this cytoplasmic NF-
κB was observed in cultured seminiferous
tubules, the physiological significance of this
finding remains obscure.
During in vitro-induced testicular apoptosis, the
Sertoli cell nuclear NF-κB expression and the
whole seminiferous tubule NF-κB DNA binding
activity increased strongly before the onset of
nuclear apoptosis. Thus, it was of interest that
apoptosis was induced in late meiotic and
postmeiotic germ cells, while the Sertoli cells
containing the inducible NF-κB survived. NF-
κB activation of the Sertoli cells may therefore
serve to protect the Sertoli cells themselves and,
simultaneously, to induce Sertoli cell production
of factors that are able to mediate germ cell death.
This would be a reasonable way for the Sertoli
cells to act, since they are essential for functional
spermatogenesis and they are terminally
differentiated cells with no capacity for renewal
(8). Interestingly, induction of testicular NF-κB
DNA binding activity was completely blocked
by the anti-inflammatory aminosalicylate drug
sulfasalazine, which has also been shown to
specifically inhibit NF-κB activation in colon
epithelial cells and in Jurkat T cells (183).
Concomitantly, germ cell apoptosis was
effectively suppressed, supporting the
hypothesized role for NF-κB as one of the factors
controlling stress-induced germ cell death.
However, the Sertoli cells survived despite
sulfasalazine treatment, suggesting that Sertoli
cell survival does not depend on their activation
of NF-κB.
Sulfasalazine has previously been reported to
inhibit NF-κB activation by directly inhibiting
the IκB kinases α and β, which leads to
inhibition of IκBα degradation (184). In the
present study, sulfasalazine inhibited neither
IκBα degradation nor nuclear translocation of
the RelA subunit, but prevented the formation
of new IκBα protein, thus resulting in the
absence of IκBα from sulfasalazine-treated
seminiferous tubules. This most likely indicates
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a decrease in NF-κB mediated transcriptional
activation of the IκBα gene. Interestingly, the
cytoplasmic NF-κB in some immature germ cells
did not translocate into the nucleus, despite the
disappearance of the IκBα. This may indicate
that the type of IκB in these cells is other than
IκBα. Indeed, high levels of IκBβ and IκBε
mRNA have been found in the testis (227,228),
which suggests that these forms of IκB
participate in the regulation of testicular NF-κB.
Finally, we wished to find out whether the
testicular expression of FasL is regulated by NF-
κB, because this cytokine plays an important
role in the control of germ cell apoptosis
(140,142), and because, in certain forms of
apoptosis, its expression has been shown to be
directly regulated by NF-κB (170,171). The
expression of the FasL is up-regulated during
culture of the seminiferous tubules. If this was
due to NF-κB dependent transcription of the
gene encoding the FasL, then sulfasalazine,
which effectively blocks NF-κB DNA binding
activity, should affect the expression of the
FasL. However, we found no effect of
sulfasalazine on the levels of the FasL,
suggesting that NF-κB does not regulate
testicular FasL gene expression during in vitro-
induced germ cell apoptosis. This agrees with
the result showing that TNFα-mediated
inhibition of germ cell apoptosis is associated
with down-regulation of the FasL, but not with
modulation of the inducible NF-κB activity. Thus,
it can be suggested that in a testicular stress
situation caused by external disturbances, the
NF-κB- and FasL-mediated pathways would
function in parallel to regulate human testicular
germ cell death, or the final action of NF-κB
would take place downstream of the action of
FasL (Figure 10).
Fig. 10. Fas- and TNFR1-mediated
signaling in the regulation of male
germ cell death. The cartoon is based
on results from several species, and
species specific-differences in the
pathways il lustrated may exist. In
several species, activation of germ cell
Fas by FasL induces apoptosis of these
cells. This apoptosis appears to be
mediated by caspases, since in the
human testis in vitro the broad-range
caspase inhibitor Z-VAD.FMK prevents
germ cell death. FasL appears to be
constitutively expressed by the Sertoli
cells. The testicular level of FasL is
elevated during Sertoli cell injury and
under exposure to external stress. In
contrast to the death-inducing Fas
system, the TNFα-mediated signaling
appears to prevent germ cell death
under apoptosis-inducing conditions.
Germ cells produce TNFα, which most
likely acts on TNFR1 on Sertoli cells. In
cultured human seminiferous tubules, TNFα inhibits germ cell apoptosis and this effect is associated with
down-regulation of the FasL. In the rat, but not in man, TNFα induces increased Sertoli cell NF-κB activity.
In contrast, in the human testis, in vitro exposure to apoptosis-inducing conditions results in Sertoli cell
activation of NF-κB, which may exert pro-apoptotic effects on germ cells.
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Prevention of stress-
induced male germ cell
apoptosis by anti-
inflammatory drugs
In the present study, several common anti-
inflammatory drugs were found to suppress in
vitro-induced death of male germ cells. The anti-
apoptotic effect of sulfasalazine may, at least
partly, be mediated through inhibition of Sertoli
cell NF-κB. Because of the general anti-
inflammatory action of SS, other simultaneous
NF-κB-independent pathways directly affecting
either the Sertoli cells or the germ cells may also
contribute to sulfasalazine-mediated germ cell
survival. Of the other anti-inflammatory drugs
tested, aspirin and sulindac have previously
been reported to inhibit NF-κB in some types of
cell, whereas indomethasin should not affect
NF-κB (186,187). All these compounds were, to
some extent, able to inhibit germ cell death, but
not NF-κB, in cultured seminiferous tubules.
Thus, the anti-apoptotic effects of these
compounds seem to be mediated by
mechanisms other than Sertoli cell NF-κB
inhibition and may be based on their other
effects, such as cyclo-oxygenase inhibition, or
on their antioxidative properties. Although this
result could be interpreted as showing that NF-
κB activation does not play an obligatory role
in the induction of testicular apoptosis, it seems
more likely to reflect the presence of many
compensatory or parallel apoptotic pathways
in the testis.
Irrespective of the mechanism of their anti-
apoptotic effect, the anti-inflammatory drugs
were able to inhibit stress-induced male germ
cell death. Importantly, at least after the
sulfasalazine and aspirin treatments, the overall
tissue morphology appeared to be undisturbed.
Moreover, the apoptotic death of meiotic and
postmeiotic germ cells could be modulated by
these drugs, with no hazardous effects on the
Sertoli cells, which are needed for continuing
spermatogenesis. Our results are supported by
reports of reversible infertility and of sperm
abnormalities, including abnormally large
numbers of immature germ cells in the sperm, in
men treated with sulfasalazine for inflammatory
bowel diseases (229-233). These findings
suggest that sulfasalazine also affects germ cell
maturation and apoptosis in vivo. Moreover,
the reversibility of the infertility supports our
observation that only the apoptotic death of
the germ cells in later phases of maturation is
affected by the sulfasalazine treatment, leaving
the Sertoli cells and the immature germ cells
undisturbed and potentially capable of
functional spermatogenesis after cessation of
the treatment. In conclusion, our results
obtained with anti-inflammatory drugs raise the
possibility that they could be used
therapeutically to prevent male germ cell death
induced by transient testicular stress situations.
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The present in vitro studies on human testicular apoptosis suggest an important role for estrogens
in the survival of male germ cells. Furthermore, they show that the signaling pathways initiated by
the cellular death receptors Fas and TNFR1 are involved in the regulation of in vitro-induced male
germ cell apoptosis. While the Fas system mediates germ cell death, the TNFα-induced signaling
is associated with down-regulation of the Fas system and inhibition of germ cell apoptosis.
Finally, the transcription factor NF-κB is suggested to regulate testicular apoptotic pathways
which function in parallel with or downstream of that triggered by Fas. That the pathways described
in the present studies regulate germ cell death in cultured human seminiferous tubules suggests
that they also regulate germ cell apoptosis during spermatogenesis and are involved in increased
germ cell death during testicular stress. Importantly, germ cell death was prevented by
pharmacological modulation of the apoptotic pathways described in the present studies. Many of
the compounds with anti-apoptotic properties are common anti-inflammatory drugs. These findings
raise the possibility that male germ cell death could be prevented in vivo during situations involving
excessive germ cell loss, such as during cancer therapies.
The potential use of anti-apoptotic compounds in humans in vivo requires careful evaluation of
the capability of the seminiferous epithelium for functional spermatogenesis after the treatments.
This evaluation should be done both in animal models and, in view of species specificity, also in
a culture model of human seminiferous epithelium. Thus, in addition to studying the apoptosis-
inhibiting capability of the candidate compounds, detailed morphological analysis of the cells of
the seminiferous epithelium should be performed and continuous spermatogenesis should be
assured. Since various disrupters, e.g. radiation or chemotherapy, may cause selective injury of
either germ cells or supporting Sertoli cells, the ability of the individual compounds to prevent
injury caused by such disrupters should be investigated. Finally, pharmacological inhibition of
pathways that eliminate injured cells could lead to preservation of transformed cells, which could
potentially cause tumorgenesis and transmission of mutations in the germ line. Accordingly,
generation of healthy offspring after apoptosis-inhibiting treatments should be confirmed in
studies employing experimental animals. Only after completion of these experiments should studies
be initiated in humans in vivo.
Conclusions and Future Prospects
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